1
|
Viani S, Segreti L, Ottaviano L, Biffi M, Nigro G, Ricciardi G, Francia P, D’onofrio A, Bisignani G, Dello Russo A, De Filippo P, Solimene F, Scalone A, Botto G, Migliore F. Real-world survival of model-3501 subcutaneous implantable defibrillator lead. Europace 2022. [DOI: 10.1093/europace/euac053.451] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: None.
Background
In December 2020, the subcutaneous implantable cardioverter-defibrillator (S-ICD) lead model-3501 was subject to a safety notification because of increased risk of fracture at a location just distal to the proximal sense ring. The manufacturer’s product performance report currently reports a lead survival probability of 98.8% at 45 months. However, no multicenter long-term performance information exists for this lead.
Purpose
Our aim was to assess the longevity of model-3501 leads and to compare it with that of the previous model-3401.
Methods
This analysis included consecutive patients who received an S-ICD with a model-3501 or a model-3401 lead at 66 Italian participating centers of the Rhythm Detect registry. A lead failed if it required extraction/replacement because of abnormalities suggestive of a structural defect, e.g. out-of-range impedance, nonphysiological electrical noise or ineffective therapy.
Results
From January 2013 to July 2021, 2403 patients were implanted and followed up (78% male, age 49±15years, ejection fraction 45±16%, body mass index 26±4Kg/m2). A 3501-model lead was used in 1697 patients and a 3401-model in 706 patients. During a median follow-up of 38 months [25th–75th percentile: 24-55], we detected 4 malfunctioning model-3501 leads and 2 model-3401 leads. After analysis of the returned leads by the manufacturer’s technical services, a single model-3501 lead failure was a fracture distal to the proximal ring electrode, as described in the manufacturer’s advisory letter. No deaths or permanent injuries occurred as a result of lead failures. The survival of 3501-model leads at 4 years was 99.5% (95% confidence interval, 99.0 to 99.9) compared with 99.9% (95% confidence interval, 99.6 to 100.0) of 3401-model leads (p=0.110). The cumulative occurrence rate of the 3501-model safety notification fracture was 0.1% (95% confidence interval, 0.0 to 0.3).
Conclusions
In this large multicenter analysis, the survival probability of model-3501 S-ICD leads was in line with that reported by the manufacturer, was not significantly lower than that of 3401-model leads (not affected by a safety notification), and still higher than that reported with transvenous leads. Although an enhanced electrode is now available, which addresses the potential for electrode body fracture, the present findings are reassuring and may have significant implications for the management of patients who have affected leads.
Collapse
Affiliation(s)
- S Viani
- Azienda Ospedaliero Universitaria Pisana, Pisa, Italy
| | - L Segreti
- Azienda Ospedaliero Universitaria Pisana, Pisa, Italy
| | - L Ottaviano
- Clinical Institute Saint Ambrogio, Milan, Italy
| | - M Biffi
- S. Orsola-Malpighi Policlinic, Bologna, Italy
| | - G Nigro
- University of Campania Luigi Vanvitell, Naples, Italy
| | - G Ricciardi
- Careggi University Hospital, Florence, Italy
| | | | | | - G Bisignani
- Civil Hospital Ferrari - Castrovillari, Castrovillari, Italy
| | | | | | | | | | - G Botto
- ASST Rhodense, Garbagnate Milanese, Italy
| | | |
Collapse
|
2
|
Casula M, De Toni C, Pignalosa L, Savastano S, Schintu B, Sanzo A, Scalone A, Tola G, Corda M, Vicentini A, Rordorf R. Temporal trend of QRS voltage amplitude on surface sensing in patients with arrhythmogenic cardiomyopathy implanted with a subcutaneous ICD. Europace 2022. [DOI: 10.1093/europace/euac053.531] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: None.
Introduction
Previous studies have reported a significant decrease in ventricular sensing amplitude during follow-up in patients with arrhythmogenic cardiomyopathy (ACM) implanted with trans-venous implantable cardioverter defibrillator (ICD). No data are yet available on sensing amplitudes values over time for subcutaneous ICD (S-ICD). Low QRS voltage on surface ECG is one of the diagnostic clues in ACM. This, together with the progressive nature of the disease and the not-negligible incidence of inappropriate shocks due to oversensing, raise safety concerns on the use of S-ICD in this population.
Aim
The aim of this study was to evaluate the trend of QRS amplitude on subcutaneous ECG (S-ECG) over time in patients with ACM implanted with S-ICD.
Methods
We conducted a retrospective analysis on a cohort of consecutive patients with ACM implanted with S-ICD in two tertiary centers, prospectively enrolled in the home-monitoring program. The S-ECGs recorded by the S-ICD at the time of first and last data transmission were analyzed. The voltage amplitude was estimated for each QRS complex available, and the values obtained were compared between the two time points (i.e. baseline and last follow-up available). The primary endpoint of our study was the proportion of patients in which the decrease of QRS amplitude during follow-up was statistically significant.
Results
Eleven patients (1 female, 9%) were enrolled in this study. The mean age was 43±10 years. An exclusive right ventricular involvement was reported in 5 patients (46%), 2 patients (18%) had an exclusive left ventricular, and 4 (36%) a biventricular involvement. Three patients (27%) were implanted in secondary prevention. During a median follow-up of 9 months (IQR 6-17), 6 patients (55%, 95%CI 24-84%) experienced a statistically significant reduction in the S-ECG QRS amplitude (Figure A). Considering these 6 patients, the mean absolute reduction was -0.46±0.32 mV corresponding to a relative reduction of -19%±11%. Moreover, we found a statistically significant correlation between follow-up duration and QRS amplitude relative reduction (r=-0.89, p=0.018, Figure B). No patients experienced inappropriate shocks.
Conclusions
In a cohort of ACM patients implanted with S-ICD the majority of patients experienced a significant reduction in the amplitude of QRS voltage during follow-up, confirming a potential safety concern on the use of S-ICD in this population. Further studies are needed to investigate this issue.
Collapse
Affiliation(s)
- M Casula
- Policlinic Foundation San Matteo IRCCS, Division of Cardiology, Pavia, Italy
| | - C De Toni
- ARNAS "G. Brotzu", Unit of Cardiology, Cagliari, Italy
| | - L Pignalosa
- Policlinic Foundation San Matteo IRCCS, Division of Cardiology, Pavia, Italy
| | - S Savastano
- Policlinic Foundation San Matteo IRCCS, Division of Cardiology, Pavia, Italy
| | - B Schintu
- ARNAS "G. Brotzu", Unit of Cardiology, Cagliari, Italy
| | - A Sanzo
- Policlinic Foundation San Matteo IRCCS, Division of Cardiology, Pavia, Italy
| | - A Scalone
- ARNAS "G. Brotzu", Unit of Cardiology, Cagliari, Italy
| | - G Tola
- ARNAS "G. Brotzu", Unit of Cardiology, Cagliari, Italy
| | - M Corda
- ARNAS "G. Brotzu", Unit of Cardiology, Cagliari, Italy
| | - A Vicentini
- Policlinic Foundation San Matteo IRCCS, Division of Cardiology, Pavia, Italy
| | - R Rordorf
- Policlinic Foundation San Matteo IRCCS, Division of Cardiology, Pavia, Italy
| |
Collapse
|
3
|
Casula M, De Toni C, Mameli S, Schintu B, Setzu A, Scalone A, Pasqualucci D, Tola G, Corda M. P27 MONOMORPHIC VENTRICULAR TACHYCARDIA INDUCED BY BLUNT CHEST TRAUMA IN A YOUNG MAN WITHOUT STRUCTURAL HEART DISEASE: A CASE REPORT. Eur Heart J Suppl 2022. [DOI: 10.1093/eurheartj/suac012.025] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
Abstract
Introduction
Life–threatening ventricular arrhythmias secondary to chest trauma without structural cardiac damage (i.e. commotio cordis [CC]) are a rare but dramatic cause of sudden cardiac death. We present a case of fast ventricular tachycardia (VT) induced by blunt chest trauma in a healthy man during sports activity.
Case Presentation
A 22–year–old man, competitive soccer player, was admitted to our hospital for VT. A few hours before admission, after a heavy ball impact in the chest during a soccer match, he suddenly reported fast and regular palpitation with lightheadedness and dyspnea, without loss of consciousness. The emergency medical service was activated, and the evaluation revealed a hemodynamically tolerated monomorphic VT with a rate of almost 285 bpm (Fig.A). Amiodaron infusion was ineffective and sinus rhythm (SR) was restored by electrical cardioversion. At the time of admission, he was asymptomatic. Familiar history, past medical history and physical examination were unremarkable. ECG revealed regular SR, with minimal right bundle branch conduction delay (Fig.B). Blood samples showed normal blood cells count, electrolyte concentrations and liver, kidney, and thyroid function; seriate high sensitivity troponin I determinations were negative. Echocardiography and cardiac magnetic resonance showed normal findings. Computed tomography angiography excluded coronary anomalies. Exercise test revealed no signs of cardiac ischemia and no effort–induced arrhythmias. The fluoroscopy–free unipolar and bipolar voltage maps showed normal electrograms throughout the right ventricle (Fig.C). No sustained arrhythmias were induced by programmed ventricular stimulation. The patient was then discharged with the indication to cardiology follow–up and the advice to avoid contact sports activities.
Discussion
VT is a rare presentation of CC. It has been proposed that CC occurs when a chest strike timed at the upstroke of the T–wave causes both ventricular depolarization trigger and altered dispersion of repolarization, mainly via activation of KATP channels. In the absence of structural heart disease (SHD), the usual presenting rhythm is ventricular fibrillation and there are no accepted mechanisms to explain monomorphic VT in this context. Some authors reported monomorphic VT after chest trauma as the first manifestation of arrhythmogenic cardiomyopathy. Therefore, a careful follow–up will be needed to exclude future development of SHD in this patient.
Collapse
Affiliation(s)
- M Casula
- U.O.C. CARDIOLOGIA – ARNAS “G. BROTZU”, CAGLIARI
| | - C De Toni
- U.O.C. CARDIOLOGIA – ARNAS “G. BROTZU”, CAGLIARI
| | - S Mameli
- U.O.C. CARDIOLOGIA – ARNAS “G. BROTZU”, CAGLIARI
| | - B Schintu
- U.O.C. CARDIOLOGIA – ARNAS “G. BROTZU”, CAGLIARI
| | - A Setzu
- U.O.C. CARDIOLOGIA – ARNAS “G. BROTZU”, CAGLIARI
| | - A Scalone
- U.O.C. CARDIOLOGIA – ARNAS “G. BROTZU”, CAGLIARI
| | | | - G Tola
- U.O.C. CARDIOLOGIA – ARNAS “G. BROTZU”, CAGLIARI
| | - M Corda
- U.O.C. CARDIOLOGIA – ARNAS “G. BROTZU”, CAGLIARI
| |
Collapse
|
4
|
Casula M, Binaghi G, Mameli S, De Toni C, Scotto R, Schintu B, Scalone A, Tola G, Corda M. P31 PERCUTANEOUS LEFT STELLATE GANGLION BLOCK AS PRE–TREATMENT STRATEGY FOR HIGH–RISK PATIENTS WHO ARE CANDIDATES FOR INVASIVE PROCEDURES POTENTIALLY ASSOCIATED WITH ADRENERGIC STIMULATION: AN HYPOTHESIS–GENERATING CASE REPORT. Eur Heart J Suppl 2022. [DOI: 10.1093/eurheartj/suac012.029] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
Abstract
Abstract
Introduction
Percutaneous left stellate ganglion block (PLSGB) has been reported as a safety and effective procedure for the management of refractory arrhythmic storm (AS). In this report we present a case of a man with refractory AS effectively treated with PLSGB, subsequently candidate for an invasive procedure potentially associated with adrenergic stimulation and propose the use of this technique as pre–treatment strategy in this clinical setting.
Case presentation
A 57–year–old man was admitted to our hospital for AS. Past medical history revealed that two years earlier he had been treated with primary percutaneous coronary intervention for ST–segment elevation myocardial infarction. Four months before admission he underwent coronary artery bypass graft surgery with concomitant mechanical mitral valve replacement, closure of an interventricular defect and, considering the severe left ventricular disfunction, he was implanted with an automatic defibrillator in primary prevention. At the time of admission, he was treated with lidocaine infusion with remission of arrhythmic events. Comprehensive diagnostic workup revealed no overt triggers for AS. Five days after admission, the patient experienced recurrence of ventricular arrhythmias (VA), refractory to amiodarone, lidocaine, and magnesium infusion, increased pacing rate, and sedation with dexmedetomidine. PLSGB was then attempted with the injection of lidocaine and ropivacaine using an anatomical approach with complete remission of arrhythmic events. After a week free from VAs, a new AS was observed and PLSGB was repeated using the same modality with complete arrhythmic resolution. Considering the advanced heart failure, the patient was candidate to heart transplantation (HT) and, before undergoing gastro– and colonoscopy required for inclusion in the HT program, with the aim to reduce the risk of VA recurrences triggered by potential adrenergic stimulation, we pre–treated the patient with PLSGB using only ropivacaine, with successful induction of temporary Horner syndrome (Fig. A). The endoscopy procedures were performed successfully with no VA events and the patient was then discharged waiting for HT.
Conclusion
We propose the use of PLSGB as a pre–treatment strategy for patients at high–risk of VAs who are candidates for invasive procedures potentially associated with adrenergic stimulation. This report could be hypotheses–generating for further studies on this topic.
Collapse
Affiliation(s)
- M Casula
- U.O.C. CARDIOLOGIA – ARNAS “G. BROTZU”, CAGLIARI
| | - G Binaghi
- U.O.C. CARDIOLOGIA – ARNAS “G. BROTZU”, CAGLIARI
| | - S Mameli
- U.O.C. CARDIOLOGIA – ARNAS “G. BROTZU”, CAGLIARI
| | - C De Toni
- U.O.C. CARDIOLOGIA – ARNAS “G. BROTZU”, CAGLIARI
| | - R Scotto
- U.O.C. CARDIOLOGIA – ARNAS “G. BROTZU”, CAGLIARI
| | - B Schintu
- U.O.C. CARDIOLOGIA – ARNAS “G. BROTZU”, CAGLIARI
| | - A Scalone
- U.O.C. CARDIOLOGIA – ARNAS “G. BROTZU”, CAGLIARI
| | - G Tola
- U.O.C. CARDIOLOGIA – ARNAS “G. BROTZU”, CAGLIARI
| | - M Corda
- U.O.C. CARDIOLOGIA – ARNAS “G. BROTZU”, CAGLIARI
| |
Collapse
|
5
|
Casula M, De Toni C, Pignalosa L, Savastano S, Schintu B, Scalone A, Corda M, Vicentini A, Tola G, Rordorf R. P9 TEMPORAL TREND OF QRS VOLTAGE AMPLITUDE ON SURFACE SENSING IN PATIENTS WITH ARRHYTHMOGENIC CARDIOMYOPATHY IMPLANTED WITH A SUBCUTANEOUS ICD. Eur Heart J Suppl 2022. [DOI: 10.1093/eurheartj/suac012.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
Abstract
Abstract
Introduction
Previous studies have reported a significant decrease in ventricular sensing amplitude during follow–up in patients with arrhythmogenic cardiomyopathy (ACM) implanted with trans–venous implantable cardioverter defibrillator (ICD). No data are yet available on sensing amplitude values over time for subcutaneous ICD (S–ICD). Low QRS voltage on surface ECG is one of the diagnostic clues in ACM. This, together with the progressive nature of the disease and the not–negligible incidence of inappropriate shocks due to oversensing, raise safety concerns on the use of S–ICD in this population. The aim of this study was to evaluate the trend of QRS amplitude on subcutaneous ECG (S–ECG) over time in patients with ACM implanted with S–ICD.
Methods
We conducted a retrospective analysis on a cohort of consecutive patients with ACM implanted with S–ICD in two Italian tertiary centers, prospectively enrolled in the home–monitoring program. The S–ECGs recorded at the time of first and last data transmission were analyzed. The voltage amplitude was estimated for each QRS complex available, and the values obtained were compared between the two time points (i.e. baseline and last follow–up available). The primary endpoint of our study was the proportion of patients in which the decrease of QRS amplitude during follow–up was statistically significant.
Results
Eleven patients (1 female, 9%) were enrolled in this study. The mean age was 43±10 years. An exclusive right ventricular involvement was reported in 5 patients (46%), 2 patients (18%) had an exclusive left ventricular, and 4 (36%) a biventricular involvement. Three patients (27%) were implanted in secondary prevention. During a median follow–up of 9 months (IQR 6–17), 6 patients (55%, 95%CI 24–84%) experienced a statistically significant reduction in the S–ECG QRS amplitude (Fig. A). Considering these 6 patients, the mean absolute reduction was –0.46±0.32 mV corresponding to a relative reduction of –19%±11%. Moreover, we found a statistically significant correlation between follow–up duration and QRS amplitude relative reduction (r=–0.89, p = 0.018, Fig. B). No patients experienced inappropriate shocks.
Conclusions
In a cohort of ACM patients implanted with S–ICD the majority of patients experienced a significant reduction in the amplitude of QRS voltage during follow–up, confirming a potential safety concern on the use of S–ICD in this population. Further studies are needed to investigate this issue.
Collapse
Affiliation(s)
- M Casula
- DIVISIONE DI CARDIOLOGIA – FONDAZIONE IRCCS POLICLINICO “SAN MATTEO”, PAVIA; U.O.C. CARDIOLOGIA – ARNAS “G. BROTZU”, CAGLIARI
| | - C De Toni
- DIVISIONE DI CARDIOLOGIA – FONDAZIONE IRCCS POLICLINICO “SAN MATTEO”, PAVIA; U.O.C. CARDIOLOGIA – ARNAS “G. BROTZU”, CAGLIARI
| | - L Pignalosa
- DIVISIONE DI CARDIOLOGIA – FONDAZIONE IRCCS POLICLINICO “SAN MATTEO”, PAVIA; U.O.C. CARDIOLOGIA – ARNAS “G. BROTZU”, CAGLIARI
| | - S Savastano
- DIVISIONE DI CARDIOLOGIA – FONDAZIONE IRCCS POLICLINICO “SAN MATTEO”, PAVIA; U.O.C. CARDIOLOGIA – ARNAS “G. BROTZU”, CAGLIARI
| | - B Schintu
- DIVISIONE DI CARDIOLOGIA – FONDAZIONE IRCCS POLICLINICO “SAN MATTEO”, PAVIA; U.O.C. CARDIOLOGIA – ARNAS “G. BROTZU”, CAGLIARI
| | - A Scalone
- DIVISIONE DI CARDIOLOGIA – FONDAZIONE IRCCS POLICLINICO “SAN MATTEO”, PAVIA; U.O.C. CARDIOLOGIA – ARNAS “G. BROTZU”, CAGLIARI
| | - M Corda
- DIVISIONE DI CARDIOLOGIA – FONDAZIONE IRCCS POLICLINICO “SAN MATTEO”, PAVIA; U.O.C. CARDIOLOGIA – ARNAS “G. BROTZU”, CAGLIARI
| | - A Vicentini
- DIVISIONE DI CARDIOLOGIA – FONDAZIONE IRCCS POLICLINICO “SAN MATTEO”, PAVIA; U.O.C. CARDIOLOGIA – ARNAS “G. BROTZU”, CAGLIARI
| | - G Tola
- DIVISIONE DI CARDIOLOGIA – FONDAZIONE IRCCS POLICLINICO “SAN MATTEO”, PAVIA; U.O.C. CARDIOLOGIA – ARNAS “G. BROTZU”, CAGLIARI
| | - R Rordorf
- DIVISIONE DI CARDIOLOGIA – FONDAZIONE IRCCS POLICLINICO “SAN MATTEO”, PAVIA; U.O.C. CARDIOLOGIA – ARNAS “G. BROTZU”, CAGLIARI
| |
Collapse
|
6
|
Ziacchi M, Capucci A, Tola G, Scaglione M, D"onofrio A, Guerra F, Scalone A, Battaglia A, D"alterio G, Biffi M. Wearable Cardioverter Defibrillator (WCD) in Italy: results from the nationwide multicenter registry WEAR-ITA. Europace 2021. [DOI: 10.1093/europace/euab116.364] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: None.
BACKGROUND
The Wearable Cardioverter Defibrillators (WCD) has been used extensively in Italy since 2015, following long years of experience in other countries. This technology provides temporary protection from Sudden Cardiac Death (SCD) for patients with an evolving risk profile that may not yet be eligible for an Implantable Cardioverter Defibrillator (ICD). Collecting national data on use of the device can help build a picture that will enable an understanding on how to use the WCD appropriately in the future.
PURPOSE
Our purpose has been to investigate WCD usage on a nationwide level. This is in terms of target population, average wear time, patient compliance, diagnosed and treated arrhythmic events and patient outcome once they stopped wearing the device.
METHODS
WEAR-ITA is a nationwide, multi-centre retrospective observational project. Patient data was retrospectively collected from the Italian hospitals that agreed to take part in the data collection for all patients fitted with a WCD between April 2015 to May 2018. All data refers to the range from the first day of wear until the end of use.
RESULTS
We collected data for 411 patients from 15 (75%) Italian regions. WCD use among the different regions was heterogeneous with a median of 0.5 (0.2-1.2) WCD wore/105 inhabitants. The mean age of the population was 55(±14) and the majority of patients were male (79%). Main WCD indication was non-ischemic cardiomyopathy with reduced ejection fraction (51%), ischemic etiology with severe systolic dysfunction (31%), uncertain or unidentified diagnosis (10%) that then revealed to be predominantly channelopathies or myocarditis and after ICD extraction (8%). Patients wore the WCD for a median of 59 (33-90) days and the median daily weartime was 23 (22,7-23,8) hours. In 15 patients (4%), the WCD recorded non sustained ventricular tachycardia (VT), 10 patients (2%) had hemodynamically well-tolerated sustained VT not needing a shock. 8 patients (2%) received effective appropriate shocks. Time to episodes were respectively 61 (14-61) days for non-sustained VT and 28 (19-70) days for VT/VF. 2 patients (0.5%) received inappropriate shocks for sinus tachycardia and atrial fibrillation (AF) respectively. WCD recorded new onset of supra ventricular tachycardia episodes in 12 patients (3%) and of atrial fibrillation (AF) in 7 patients (2%). 7 patients (2%) died while wearing WCD; none of them from SCD. At the end of the WCD use, 195 patients (47%) did not receive an ICD while 209 patients (51%)were implanted.
CONCLUSIONS
WCD is an effective therapy for the treatment of SCD with a very low complication rates. The indication and penetration in Italy is quite heterogeneous. The patient’s compliance is high over time. The incidence of appropriate shock is not negligible; only half of patients, who wore WCD, received an ICD. There is however still a requirement to conduct further randomized trials to understand which patients could most benefit from the use of WCD. Abstract Figure. Wereable Cardioverter Defibrillator
Collapse
Affiliation(s)
- M Ziacchi
- Azienda Ospedaliero, Universitaria di Bologna, Policlinico S.Orsola-Malpigh, Institute of Cardiology, Department of Experimental, Diagnostic and Specialty Medicine, Bologna, Italy
| | - A Capucci
- Marche Polytechnic University of Ancona, Cardiology and Arrhythmology Clinic, University Hospital Umberto, Lancisi, Salesi, Ancona, Italy
| | - G Tola
- AO Brotzu Hospital, Division of Cardiology, Cagliari, Italy
| | - M Scaglione
- Cardinal Massaia Hospital, Division of Cardiology, Asti, Italy
| | - A D"onofrio
- Ospedale Monaldi, Departmental Unit of Electrophysiology, Evaluation and Treatment of Arrhythmias, Naples, Italy
| | - F Guerra
- Marche Polytechnic University of Ancona, Cardiology and Arrhythmology Clinic, University Hospital Umberto, Lancisi, Salesi, Ancona, Italy
| | - A Scalone
- AO Brotzu Hospital, Division of Cardiology, Cagliari, Italy
| | - A Battaglia
- Cardinal Massaia Hospital, Division of Cardiology, Asti, Italy
| | - G D"alterio
- Ospedale Monaldi, Departmental Unit of Electrophysiology, Evaluation and Treatment of Arrhythmias, Naples, Italy
| | - M Biffi
- Azienda Ospedaliero, Universitaria di Bologna, Policlinico S.Orsola-Malpigh, Institute of Cardiology, Department of Experimental, Diagnostic and Specialty Medicine, Bologna, Italy
| |
Collapse
|
7
|
Ziacchi M, Bisignani G, Palmisano P, Scalone A, Martignani C, Mocavero PE, Caravati F, Della Cioppa N, Mazzuero A, Pecora D, Vicentini A, Landolina ME, Lovecchio M, Valsecchi S, Droghetti A. P524Serratus anterior plane block in subcutaneous implantable cardioverter defibrillator implantation: a case-control analysis. Europace 2020. [DOI: 10.1093/europace/euaa162.142] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Funding Acknowledgements
No Funding
OnBehalf
RHYTHM DETECT study group
Background
A two-incision technique, in association with inter-muscular positioning of the subcutaneous defibrillator (S-ICD), is now the most frequently adopted implantation approach in Europe. Ultrasound-guided serratus anterior plane block (SAPB) has been proposed in order to provide anesthesia/analgesia during S-ICD implantation.
Objective
We performed a case-control analysis in which a standardized SAPB approach was compared with the typical local anesthesia and sedation approach.
Methods
91 consecutive patients underwent implantation of an S-ICD with the SAPB approach for anesthesia/analgesia at 10 centers. The control group consisted of 55 consecutive patients who underwent S-ICD implantation with standard local approach.
Results
The mean procedure duration was 59 ± 15min in the SAPB group and 76 ± 23min in the control group (p < 0.001). No operative complications were reported in either group. During the procedure, 79 (87%) patients in the SAPB group and 25 (46%) patients in the control group (p < 0.001) remained awake. Lower values of pain intensity at the device pocket (p = 0.005) and the lateral tunneling site (p = 0.046) were reported in the SAPB group. The difference in static (p = 0.002) and dynamic (p = 0.007) pain intensity between the groups persisted at 1 hour, while no differences were observed 6 hours after the end of the procedure.
Conclusions
SAPB is feasible and effective in providing anesthesia/analgesia during S-ICD implantation. The procedures were successfully accomplished and no complications occurred in either group. However, SAPB was associated with lower pain levels, enabling the need for sedation to be reduced and more patients to remain awake. Moreover, it resulted in shorter procedure durations.
Collapse
Affiliation(s)
- M Ziacchi
- Azienda Ospedaliero, Universitaria di Bologna, Policlinico S.Orsola-Malpigh, Bologna, Italy
| | - G Bisignani
- Hospital Ferrari, Cardiology, Castrovillari, Italy
| | - P Palmisano
- Cardinale G. Panico Hospital, Tricase, Italy
| | | | - C Martignani
- Azienda Ospedaliero, Universitaria di Bologna, Policlinico S.Orsola-Malpigh, Bologna, Italy
| | - P E Mocavero
- Parthenope University of Naples, Unità Operativa di Elettrofisiologia, Studio e Terapia delle Aritmie, Napoli, Italy
| | - F Caravati
- Circolo e Fondazione Macchi Hospital , Varese, Italy
| | - N Della Cioppa
- Second University of Naples, Monaldi Hospital, NAPOLI, Italy
| | | | - D Pecora
- Poliambulanza Foundation Hospital Institute of Brescia, Brescia, Italy
| | - A Vicentini
- Policlinic Foundation San Matteo IRCCS, Cardiology, Pavia, Italy
| | | | | | | | - A Droghetti
- ASST Mantova-Cremona, Thoracic Surgery , MANTOVA, Italy
| |
Collapse
|
8
|
Sannella AR, Karioti A, Orsini S, Scalone A, Gradoni L, Messori L, Severini C, Bilia AR. Leaf Decoction of Carica papaya Combined with Artesunate Prevents Recrudescence in Plasmodium berghei-Infected Mice. Planta Med 2019; 85:934-940. [PMID: 31216580 DOI: 10.1055/a-0952-3677] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Abstract
Malaria treatment and control have become increasingly difficult because of the spread of drug-resistant strains of Plasmodium falciparum and Plasmodium vivax. Thus, there is a continuous need to develop new combination therapies such as artemisinin-based combination therapies (ACTs) to contrast the emergence of resistant Plasmodium strains. Despite ACT has been recommended by the World Health Organization since 2001, its overall deployment in poor endemic areas is very slow, principally due to its high cost. In the malaria endemic areas, plant remedies are still widely used mostly without assurance of their efficacy and/or safety. A variety of widespread herbal drugs or natural products were already reported for their possible plasmodicidal activities, but the studies concerning their activity in combination with artemisinins are very scarce. The antimalarial activity of papaya is mostly anecdotal, and the present study is aimed at investigating the antiplasmodial activity of a decoction obtained by traditional recipe from the mature leaves of Carica papaya. The decoction was analyzed by HPLC-DAD-MS (high performance liquid chromatography coupled with diodoarray detector and mass spectrometry) showing the presence of caffeoyl derivatives and di- and triglycosides of flavonols. The extract was found to be active against P. falciparum 3D7 strains with a synergism in the presence of artemisinin. In vivo activity against the murine malaria model of Plasmodium berghei was disclosed both for the dried extract alone (250, 500, and 750 mg/kg/d) and for its combination with artesunate (250 mg/kg/d papaya plus 10 mg/kg/d artesunate). This combination displayed the greatest antimalarial activity in terms of reduction of parasitemia and prevention of recrudescence in animals recovered from the infection.
Collapse
Affiliation(s)
- Anna Rosa Sannella
- Department of Infectious Diseases, Istituto Superiore di Sanità, Rome Italy
| | - Anastasia Karioti
- Department of Pharmacognosy-Pharmacology, Aristotle University of Thessaloniki, Thessaloniki, Greece
| | - Stefania Orsini
- Department of Infectious Diseases, Istituto Superiore di Sanità, Rome Italy
| | - Aldo Scalone
- Department of Infectious Diseases, Istituto Superiore di Sanità, Rome Italy
| | - Luigi Gradoni
- Department of Infectious Diseases, Istituto Superiore di Sanità, Rome Italy
| | - Luigi Messori
- Department of Chemistry, University of Florence, Sesto Fiorentino (FI) Italy
| | - Carlo Severini
- Department of Infectious Diseases, Istituto Superiore di Sanità, Rome Italy
| | - Anna Rita Bilia
- Department of Chemistry, University of Florence, Sesto Fiorentino (FI) Italy
| |
Collapse
|
9
|
Sannella AR, Karioti A, Orsini S, Scalone A, Gradoni L, Messori L, Severini C, Bilia AR. Erratum: Leaf Decoction of Carica papaya Combined with Artesunate Prevents Recrudescence in Plasmodium berghei-Infected Mice. Planta Med 2019; 85:e7-e7. [PMID: 31330543 DOI: 10.1055/a-0978-1607] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/10/2023]
Affiliation(s)
- Anna Rosa Sannella
- Department of Infectious Diseases, Istituto Superiore di Sanità, Rome Italy
| | - Anastasia Karioti
- Department of Pharmacognosy-Pharmacology, Aristotle University of Thessaloniki, Thessaloniki, Greece
| | - Stefania Orsini
- Department of Infectious Diseases, Istituto Superiore di Sanità, Rome Italy
| | - Aldo Scalone
- Department of Infectious Diseases, Istituto Superiore di Sanità, Rome Italy
| | - Luigi Gradoni
- Department of Infectious Diseases, Istituto Superiore di Sanità, Rome Italy
| | - Luigi Messori
- Department of Chemistry, University of Florence, Sesto Fiorentino (FI) Italy
| | - Carlo Severini
- Department of Infectious Diseases, Istituto Superiore di Sanità, Rome Italy
| | - Anna Rita Bilia
- Department of Chemistry, University of Florence, Sesto Fiorentino (FI) Italy
| |
Collapse
|
10
|
Gizzarelli M, Foglia Manzillo V, Fiorentino E, Scalone A, Oliva G. Nostril mass caused by Leishmania spp. in a dog. Vet Ital 2018; 54:237-241. [PMID: 30575001 DOI: 10.12834/vetit.1460.7898.1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Received: 10/19/2017] [Revised: 02/26/2018] [Accepted: 02/19/2018] [Indexed: 11/03/2022]
Abstract
Canine leishmaniasis (CanL) is a systemic zoonotic disease caused by the protozoan Leishmania, an intracellular macrophage parasite, transmitted by the bite of phlebotomine sandflies. In dogs, the clinical disease is mostly characterised by symptoms associated with viscerocutaneous lesions such as lymphadenopathy, splenomegaly, skin lesions, and renal and ocular disease caused by the deposition of immune complexes. The parasite may provoke mucosal lesions which cause atypical clinical signs. The aim of this study is to describe an atypical nostril mass in a dog infected by Leishmania. Clinical examination did not show any systemic clinical signs, while haematological, biochemical, and urinary parameters demonstrated a mild disease stage. Diagnosis was confirmed through the isolation of cultured live parasites by biopsy. The dog was treated with a combination of miltefosine and allopurinol, showing full remission of clinical symptoms after 2 months. The authors outline the importance of considering CanL in the differential diagnosis of mucous and tumour-like lesions.
Collapse
Affiliation(s)
- Manuela Gizzarelli
- Department of Veterinary Medicine and Animal Production, University of Naples Federico II, 80137 Napoli, Italy..
| | | | | | | | | |
Collapse
|
11
|
Kostalova T, Lestinova T, Maia C, Sumova P, Vlkova M, Willen L, Polanska N, Fiorentino E, Scalone A, Oliva G, Veronesi F, Cristóvão JM, Courtenay O, Campino L, Gradoni L, Gramiccia M, Volf P. The recombinant protein rSP03B is a valid antigen for screening dog exposure to Phlebotomus perniciosus across foci of canine leishmaniasis. Med Vet Entomol 2017; 31:88-93. [PMID: 27718267 DOI: 10.1111/mve.12192] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/01/2016] [Revised: 05/25/2016] [Accepted: 06/05/2016] [Indexed: 06/06/2023]
Abstract
The frequency of sandfly-host contacts can be measured by host antibody levels against sandfly salivary proteins. Recombinant salivary proteins are suggested to represent a valid replacement for salivary gland homogenate (SGH); however, it is necessary to prove that such antigens are recognized by antibodies against various populations of the same species. Phlebotomus perniciosus (Diptera: Psychodidae) is the main vector of Leishmania infantum (Trypanosomatida: Trypanosomatidae) in southwest Europe and is widespread from Portugal to Italy. In this study, sera were sampled from naturally exposed dogs from distant regions, including Campania (southern Italy), Umbria (central Italy) and the metropolitan Lisbon region (Portugal), where P. perniciosus is the unique or principal vector species. Sera were screened for anti-P. perniciosus antibodies using SGH and 43-kDa yellow-related recombinant protein (rSP03B). A robust correlation between antibodies recognizing SGH and rSP03B was detected in all regions, suggesting substantial antigenic cross-reactivity among different P. perniciosus populations. No significant differences in this relationship were detected between regions. Moreover, rSP03B and the native yellow-related protein were shown to share similar antigenic epitopes, as canine immunoglobulin G (IgG) binding to the native protein was inhibited by pre-incubation with the recombinant form. These findings suggest that rSP03B should be regarded as a universal marker of sandfly exposure throughout the geographical distribution of P. perniciosus.
Collapse
Affiliation(s)
- T Kostalova
- Department of Parasitology, Faculty of Science, Charles University in Prague, Prague, Czech Republic
| | - T Lestinova
- Department of Parasitology, Faculty of Science, Charles University in Prague, Prague, Czech Republic
| | - C Maia
- Global Health and Tropical Medicine, Medical Parasitology Unit, Instituto de Higiene e Medicina Tropical, New University of Lisbon, Lisbon, Portugal
- Faculty of Veterinary Medicine, Lusophone University of Humanities and Technologies, Lisbon, Portugal
| | - P Sumova
- Department of Parasitology, Faculty of Science, Charles University in Prague, Prague, Czech Republic
| | - M Vlkova
- Department of Parasitology, Faculty of Science, Charles University in Prague, Prague, Czech Republic
| | - L Willen
- Department of Parasitology, Faculty of Science, Charles University in Prague, Prague, Czech Republic
| | - N Polanska
- Department of Parasitology, Faculty of Science, Charles University in Prague, Prague, Czech Republic
| | - E Fiorentino
- Unit of Vector-Borne Diseases and International Health, Istituto Superiore di Sanità, Rome, Italy
| | - A Scalone
- Unit of Vector-Borne Diseases and International Health, Istituto Superiore di Sanità, Rome, Italy
| | - G Oliva
- Department of Veterinary Medicine and Animal Production, University Federico II, Naples, Italy
| | - F Veronesi
- Department of Veterinary Medicine, University of Perugia, Perugia, Italy
| | - J M Cristóvão
- Global Health and Tropical Medicine, Medical Parasitology Unit, Instituto de Higiene e Medicina Tropical, New University of Lisbon, Lisbon, Portugal
| | - O Courtenay
- Warwick Infectious Disease Epidemiology Research (WIDER), School of Life Sciences, University of Warwick, Coventry, U.K
| | - L Campino
- Global Health and Tropical Medicine, Medical Parasitology Unit, Instituto de Higiene e Medicina Tropical, New University of Lisbon, Lisbon, Portugal
- Department of Biomedical and Medical Sciences, University of Algarve, Faro, Portugal
| | - L Gradoni
- Unit of Vector-Borne Diseases and International Health, Istituto Superiore di Sanità, Rome, Italy
| | - M Gramiccia
- Unit of Vector-Borne Diseases and International Health, Istituto Superiore di Sanità, Rome, Italy
| | - P Volf
- Department of Parasitology, Faculty of Science, Charles University in Prague, Prague, Czech Republic
| |
Collapse
|
12
|
Piantedosi D, Veneziano V, Di Muccio T, Manzillo VF, Fiorentino E, Scalone A, Neola B, Di Prisco F, D'Alessio N, Gradoni L, Oliva G, Gramiccia M. Epidemiological survey on Leishmania infection in red foxes (Vulpes vulpes) and hunting dogs sharing the same rural area in Southern Italy. Acta Parasitol 2016; 61:769-775. [PMID: 27787204 DOI: 10.1515/ap-2016-0106] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/05/2016] [Accepted: 06/29/2016] [Indexed: 11/15/2022]
Abstract
Southern Italy, particularly Campania region, is an area where canine leishmaniasis (CanL) and zoonotic human visceral leishmaniasis (VL) are endemic. The red fox (Vulpes vulpes) has been hypothesized to play a role in occurrence of CanL in Italy but specific studies are poor. The aim of the present survey was to investigate the prevalence of Leishmania infection in dogs and foxes living in the same rural area (Picentini hills). 123 sera from autochthonous fox-hunting dogs were examined by immunofluorescent-antibody test (IFAT) using a cut-off of 1:160. The seroprevalence of dogs examined was 17.9%. Moreover, 48 foxes were examined after having been shooted by hunters or road accidents. Spleen, liver and lymph node samples were analyzed by specific Leishmania nested PCR (n-PCR). 10 foxes were found infected by L. infantum (20.8%) of which 4 animals in spleen, 2 in lymph nodes and 4 both in spleen and lymph nodes. The overall n-PCR positivity was 17.4% for spleen samples and 13.3% for lymph nodes; all liver samples resulted negative. In positive PCR foxes no signs clearly referable to leishmaniasis were recorded at necropsy. The results confirmed the presence of L. infantum infection in red foxes from Southern Italy, with a moderate level of exposure. Because large proportions of dogs with ascertained progressive leishmaniasis show a prolonged "subpatent condition" during which they are only positive to n-PCR before seroconversion, our results allow to assume that exposure risk in foxes is lower than hunting dogs living in the studied area.
Collapse
|
13
|
Oliva G, Gradoni L, Cortese L, Orsini S, Ciaramella P, Scalone A, de Luna R, Persechino A. Comparative efficacy of meglumine antimoniate and aminosidine sulphate, alone or in combination, in canine leishmaniasis. Annals of Tropical Medicine & Parasitology 2016. [DOI: 10.1080/00034983.1998.11813276] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
|
14
|
Di Muccio T, Scalone A, Bruno A, Marangi M, Grande R, Armignacco O, Gradoni L, Gramiccia M. Correction: Epidemiology of Imported Leishmaniasis in Italy: Implications for a European Endemic Country. PLoS One 2015; 10:e0134885. [PMID: 26230719 PMCID: PMC4521795 DOI: 10.1371/journal.pone.0134885] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
15
|
Di Muccio T, Scalone A, Bruno A, Marangi M, Grande R, Armignacco O, Gradoni L, Gramiccia M. Epidemiology of Imported Leishmaniasis in Italy: Implications for a European Endemic Country. PLoS One 2015; 10:e0129418. [PMID: 26114938 PMCID: PMC4482607 DOI: 10.1371/journal.pone.0129418] [Citation(s) in RCA: 30] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/03/2015] [Accepted: 05/09/2015] [Indexed: 02/06/2023] Open
Abstract
In the past decade, the number of imported leishmaniasis cases has increased in countries of Western Europe. The trend is associated with increasing travels, ecotourism activity, military operations and immigration. While in endemic countries leishmaniasis is usually well diagnosed, accurate patient history and parasite identification are necessary to distinguish between autochthonous and imported cases. This is particularly important, as new Leishmania species/genotypes may be introduced and transmitted by local phlebotomine vectors without appropriate surveillance, with unpredictable consequences. We report on the surveillance of imported leishmaniasis performed by the Leishmania Identification Reference Centre of Rome from 1986 through 2012, involving health care centres from 16/20 Italian regions. Suspected imported cases were analyzed and conclusions were based on clinical, epidemiological and diagnostic findings. Over the years, different parasite identification methods were employed, including MultiLocus Enzyme Electrophoresis and molecular techniques combining disease diagnosis (SSU rDNA nested-PCR) and Leishmania typing (nuclear repetitive sequence and ITS-1 PCR-RFLPs). A total of 105 imported cases were recorded (annual range: 0-20) of which 36 were visceral (VL) (16 HIV-coinfections) and 69 cutaneous (CL) cases; 85 cases (52 CL) were from the Old World and 20 (17 CL) from the New World. Eight Leishmania species were identified, of which 7 were exotic to Italy. VL importation until 1995 was associated with the spread of Mediterranean Leishmania-HIV co-infections in early 1990s. Following the introduction of HAART treatment, such cases became occasional in Italians but relatively frequent among immigrants. In contrast, a steady increase of CL cases was observed from different areas of the Old and New Worlds, that in recent years included mainly immigrants ‘visiting friends and relatives’ and Italian tourists. This positive trend likely depends on better diagnosis and reporting; however, we suspect that many CL cases remained unrecognized. Given the relatively low incidence of leishmaniasis importation, the risk of introduction of exotic parasites appears limited, although the detection of anthroponotic species requires attention.
Collapse
Affiliation(s)
- Trentina Di Muccio
- Unit of Vector-borne Diseases & International Health, MIPI Department, Istituto Superiore di Sanità, Rome, Italy
| | - Aldo Scalone
- Unit of Vector-borne Diseases & International Health, MIPI Department, Istituto Superiore di Sanità, Rome, Italy
| | - Antonella Bruno
- Laboratory of Parasitology, Unit of Microbiology and Virology, IRCCS Policlinico San Matteo, Pavia, Italy
| | - Massimo Marangi
- Unit of Infectious Diseases, Department of Medical Sciences, Sant’Andrea Hospital, Rome, Italy
| | - Romualdo Grande
- Unit of Clinical Microbiology Virology and Bioemergencies Diagnosis, Luigi Sacco University Hospital, Milan, Italy
| | | | - Luigi Gradoni
- Unit of Vector-borne Diseases & International Health, MIPI Department, Istituto Superiore di Sanità, Rome, Italy
| | - Marina Gramiccia
- Unit of Vector-borne Diseases & International Health, MIPI Department, Istituto Superiore di Sanità, Rome, Italy
- * E-mail:
| |
Collapse
|
16
|
Kostalova T, Lestinova T, Sumova P, Vlkova M, Rohousova I, Berriatua E, Oliva G, Fiorentino E, Scalone A, Gramiccia M, Gradoni L, Volf P. Canine Antibodies against Salivary Recombinant Proteins of Phlebotomus perniciosus: A Longitudinal Study in an Endemic Focus of Canine Leishmaniasis. PLoS Negl Trop Dis 2015; 9:e0003855. [PMID: 26111018 PMCID: PMC4482481 DOI: 10.1371/journal.pntd.0003855] [Citation(s) in RCA: 33] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/06/2015] [Accepted: 05/28/2015] [Indexed: 01/28/2023] Open
Abstract
Background Phlebotomine sand flies are vectors of Leishmania parasites. During blood feeding, sand flies deposit into the host skin immunogenic salivary proteins which elicit specific antibody responses. These anti-saliva antibodies enable an estimate of the host exposure to sand flies and, in leishmaniasis endemic areas, also the risk for Leishmania infections. However, the use of whole salivary gland homogenates as antigen has several limitations, and therefore, recombinant salivary proteins have been tested to replace them in antibody detection assays. In this study, we have used for the first time sand fly salivary recombinant proteins in a longitudinal field study on dogs. Methodology/Principal Findings Sera from dogs naturally exposed to P. perniciosus bites over two consecutive transmission seasons in a site endemic for canine leishmaniasis (CanL) were tested at different time points by ELISA for the antibodies recognizing whole saliva, single salivary 43 kDa yellow-related recombinant protein (rSP03B), and a combination of two salivary recombinant proteins, 43 kDa yellow-related protein and 35.5 kDa apyrase (rSP01). Dogs were also tested for Leishmania infantum positivity by serology, culture, and PCR and the infection status was evaluated prospectively. We found a significant association between active CanL infection and the amount of anti-P. perniciosus saliva antibodies. Importantly, we detected a high correlation between IgG antibodies recognizing rSP03B protein and the whole salivary antigen. The kinetics of antibody response showed for both a whole saliva and rSP03B a similar pattern that was clearly related to the seasonal abundance of P. perniciosus. Conclusions These results suggest that P. perniciosus rSP03B protein is a valid alternative to whole saliva and could be used in large-scale serological studies. This novel method could be a practical and economically-sound tool to detect the host exposure to sand fly bites in CanL endemic areas. Canine leishmaniasis (CanL) is a widespread zoonosis caused by protozoan parasite Leishmania infantum. CanL is endemic in more than 70 countries, including regions of southwestern Europe, where the main vector is Phlebotomus perniciosus. Saliva inoculated into the host during blood feeding provoke species-specific antibody response. They could be used as a serological marker of exposure to sand flies and, in leishmaniasis endemic areas, also as an indication of Leishmania infection risk. However, in case of large-scale serological studies, it is difficult to obtain appropriate amounts of crude salivary antigen from laboratory-reared sand flies. Therefore, we studied if specific salivary recombinant proteins could be suitable to replace whole saliva as an antigen for serological assays. Antibodies recognizing recombinant salivary protein in naturally bitten dogs were highly correlated with antibody response against whole saliva. Seasonal exposure of dogs to sand flies led to antibody response fluctuations related to the period of activity and abundance of vectors. In a context of high CanL endemicity, we found a significant association between progressive CanL infections and antibodies against sand fly saliva. Thus, salivary recombinant proteins could be used as suitable tool for investigations host exposure to sand flies in endemic settings.
Collapse
Affiliation(s)
- Tatiana Kostalova
- Department of Parasitology, Faculty of Science, Charles University in Prague, Prague, Czech Republic
- * E-mail:
| | - Tereza Lestinova
- Department of Parasitology, Faculty of Science, Charles University in Prague, Prague, Czech Republic
| | - Petra Sumova
- Department of Parasitology, Faculty of Science, Charles University in Prague, Prague, Czech Republic
| | - Michaela Vlkova
- Department of Parasitology, Faculty of Science, Charles University in Prague, Prague, Czech Republic
| | - Iva Rohousova
- Department of Parasitology, Faculty of Science, Charles University in Prague, Prague, Czech Republic
| | | | - Gaetano Oliva
- Department of Veterinary Medicine and Animal Production, University Federico II, Naples, Italy
| | - Eleonora Fiorentino
- Unit of Vector-borne Diseases and International Health, Istituto Superiore di Sanità, Rome, Italy
| | - Aldo Scalone
- Unit of Vector-borne Diseases and International Health, Istituto Superiore di Sanità, Rome, Italy
| | - Marina Gramiccia
- Unit of Vector-borne Diseases and International Health, Istituto Superiore di Sanità, Rome, Italy
| | - Luigi Gradoni
- Unit of Vector-borne Diseases and International Health, Istituto Superiore di Sanità, Rome, Italy
| | - Petr Volf
- Department of Parasitology, Faculty of Science, Charles University in Prague, Prague, Czech Republic
| |
Collapse
|
17
|
Varani S, Cagarelli R, Melchionda F, Attard L, Salvadori C, Finarelli AC, Gentilomi GA, Tigani R, Rangoni R, Todeschini R, Scalone A, Di Muccio T, Gramiccia M, Gradoni L, Viale P, Landini MP. Ongoing outbreak of visceral leishmaniasis in Bologna Province, Italy, November 2012 to May 2013. Euro Surveill 2013. [DOI: 10.2807/1560-7917.es2013.18.28.20530] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
Binary file ES_Abstracts_Final_ECDC.txt matches
Collapse
Affiliation(s)
- S Varani
- Unit of Microbiology, Regional Reference Center for Microbiological Emergencies (CRREM), St. Orsola Malpighi Hospital, University of Bologna, Bologna, Italy
| | - R Cagarelli
- Public Health Authority Emilia-Romagna, Bologna, Italy
| | - F Melchionda
- Department of Pediatric Hematology and Oncology, St. Orsola Malpighi University Hospital, Bologna, Italy
| | - L Attard
- Infectious Disease Unit, St. Orsola Malpighi Hospital, University of Bologna, Italy
| | - C Salvadori
- Infectious Disease Unit, St. Orsola Malpighi Hospital, University of Bologna, Italy
| | - A C Finarelli
- Public Health Authority Emilia-Romagna, Bologna, Italy
| | - G A Gentilomi
- Unit of Microbiology, Regional Reference Center for Microbiological Emergencies (CRREM), St. Orsola Malpighi Hospital, University of Bologna, Bologna, Italy
| | - R Tigani
- Unit of Microbiology, Regional Reference Center for Microbiological Emergencies (CRREM), St. Orsola Malpighi Hospital, University of Bologna, Bologna, Italy
| | - R Rangoni
- Public Health Department of Imola, Bologna, Italy
| | - R Todeschini
- Public Health Department of Casalecchio di Reno, Bologna, Italy
| | - A Scalone
- Unit of Vector-Borne Diseases and International Health, Istituto Superiore di Sanità, Rome, Italy
| | - T Di Muccio
- Unit of Vector-Borne Diseases and International Health, Istituto Superiore di Sanità, Rome, Italy
| | - M Gramiccia
- Unit of Vector-Borne Diseases and International Health, Istituto Superiore di Sanità, Rome, Italy
| | - L Gradoni
- Unit of Vector-Borne Diseases and International Health, Istituto Superiore di Sanità, Rome, Italy
| | - P Viale
- Infectious Disease Unit, St. Orsola Malpighi Hospital, University of Bologna, Italy
| | - M P Landini
- Unit of Microbiology, Regional Reference Center for Microbiological Emergencies (CRREM), St. Orsola Malpighi Hospital, University of Bologna, Bologna, Italy
| |
Collapse
|
18
|
Gramiccia M, Scalone A, Di Muccio T, Orsini S, Fiorentino E, Gradoni L. The burden of visceral leishmaniasis in Italy from 1982 to 2012: a retrospective analysis of the multi-annual epidemic that occurred from 1989 to 2009. Euro Surveill 2013. [DOI: 10.2807/1560-7917.es2013.18.28.20535] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
Starting from 1989 Italy experienced an increase of visceral leishmaniasis (VL) cases over a baseline of 10 to 30 cases reported annually. The number of cases peaked in 2000 and 2004 with more than 200 cases/year, and subsequently declined to reach on average one third of the 2000 peak value in the period after 2010. A retrospective analysis from 1982 to 2012 showed that the multi-annual epidemic consisted of major components including (i) an outbreak involving infants and immunocompetent adults in parts of the Campania region (southern peninsular Italy) and that appears to have declined naturally, (ii) a second outbreak affecting human immunodeficiency virus (HIV)-infected individuals throughout the country, that declined owing to the use of highly active antiretroviral therapies (HAART), (iii) a generalised increase of VL cases in immunocompetent individuals and patients affected by associated conditions other than HIV from endemic regions of peninsular and insular Italy (other than Campania), which was due to a geographical spreading of VL foci, with no major case-clusters or outbreak features. A minor component consisted in the appearance of a few autochthonous cases in formerly non-endemic areas, starting from the early 1990s. Epidemic determinants and reasons for VL decline in the Campania region remain largely unexplained, despite the information available on canine reservoir and phlebotomine vectors in Italy.
Collapse
Affiliation(s)
- M Gramiccia
- Unit of Vector-borne Diseases and International Health, MIPI Department, Istituto Superiore di Sanità, Rome, Italy
| | - A Scalone
- Unit of Vector-borne Diseases and International Health, MIPI Department, Istituto Superiore di Sanità, Rome, Italy
| | - T Di Muccio
- Unit of Vector-borne Diseases and International Health, MIPI Department, Istituto Superiore di Sanità, Rome, Italy
| | - S Orsini
- Unit of Vector-borne Diseases and International Health, MIPI Department, Istituto Superiore di Sanità, Rome, Italy
| | - E Fiorentino
- Unit of Vector-borne Diseases and International Health, MIPI Department, Istituto Superiore di Sanità, Rome, Italy
| | - L Gradoni
- Unit of Vector-borne Diseases and International Health, MIPI Department, Istituto Superiore di Sanità, Rome, Italy
| |
Collapse
|
19
|
Varani S, Cagarelli R, Melchionda F, Attard L, Salvadori C, Finarelli AC, Gentilomi GA, Tigani R, Rangoni R, Todeschini R, Scalone A, Di Muccio T, Gramiccia M, Gradoni L, Viale P, Landini MP. Ongoing outbreak of visceral leishmaniasis in Bologna Province, Italy, November 2012 to May 2013. Euro Surveill 2013. [DOI: 10.2807/1560-7917.es2013.18.29.20530] [Citation(s) in RCA: 41] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
20
|
Varani S, Cagarelli R, Melchionda F, Attard L, Salvadori C, Finarelli AC, Gentilomi GA, Tigani R, Rangoni R, Todeschini R, Scalone A, Di Muccio T, Gramiccia M, Gradoni L, Viale P, Landini MP. Ongoing outbreak of visceral leishmaniasis in Bologna Province, Italy, November 2012 to May 2013. Euro Surveill 2013; 18:20530. [PMID: 23929116] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/02/2023] Open
Abstract
An increased number of autochthonous visceral leishmaniasis (VL) cases has recently been reported in Bologna Province in northern Italy. Over six months from November 2012 to May 2013, 14 cases occurred, whereas the average number of cases per year was 2.6 (range: 0-8) in 2008 to 2012. VL was diagnosed in a median of 40 days (range: 15-120) from disease onset. This delay in diagnosis shows the need for heightened awareness of clinicians for autochthonous VL in Europe.
Collapse
Affiliation(s)
- S Varani
- Unit of Microbiology, Regional Reference Center for Microbiological Emergencies (CRREM), St. Orsola Malpighi Hospital, University of Bologna, Bologna, Italy.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
21
|
Gramiccia M, Scalone A, Di Muccio T, Orsini S, Fiorentino E, Gradoni L. The burden of visceral leishmaniasis in Italy from 1982 to 2012: a retrospective analysis of the multi-annual epidemic that occurred from 1989 to 2009. Euro Surveill 2013. [DOI: 10.2807/1560-7917.es2013.18.29.20535] [Citation(s) in RCA: 59] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
22
|
Gramiccia M, Scalone A, Di Muccio T, Orsini S, Fiorentino E, Gradoni L. The burden of visceral leishmaniasis in Italy from 1982 to 2012: a retrospective analysis of the multi-annual epidemic that occurred from 1989 to 2009. Euro Surveill 2013; 18:20535. [PMID: 23929120] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/02/2023] Open
Abstract
Starting from 1989 Italy experienced an increase of visceral leishmaniasis (VL) cases over a baseline of 10 to 30 cases reported annually. The number of cases peaked in 2000 and 2004 with more than 200 cases/year, and subsequently declined to reach on average one third of the 2000 peak value in the period after 2010. A retrospective analysis from 1982 to 2012 showed that the multi-annual epidemic consisted of major components including (i) an outbreak involving infants and immunocompetent adults in parts of the Campania region (southern peninsular Italy) and that appears to have declined naturally, (ii) a second outbreak affecting human immunodeficiency virus (HIV)-infected individuals throughout the country, that declined owing to the use of highly active antiretroviral therapies (HAART), (iii) a generalised increase of VL cases in immunocompetent individuals and patients affected by associated conditions other than HIV from endemic regions of peninsular and insular Italy (other than Campania), which was due to a geographical spreading of VL foci, with no major case-clusters or outbreak features. A minor component consisted in the appearance of a few autochthonous cases in formerly non-endemic areas, starting from the early 1990s. Epidemic determinants and reasons for VL decline in the Campania region remain largely unexplained, despite the information available on canine reservoir and phlebotomine vectors in Italy.
Collapse
Affiliation(s)
- M Gramiccia
- Unit of Vector-borne Diseases and International Health, MIPI Department, Istituto Superiore di Sanità, Rome, Italy
| | | | | | | | | | | |
Collapse
|
23
|
Foglia Manzillo V, Di Muccio T, Cappiello S, Scalone A, Paparcone R, Fiorentino E, Gizzarelli M, Gramiccia M, Gradoni L, Oliva G. Prospective study on the incidence and progression of clinical signs in naïve dogs naturally infected by Leishmania infantum. PLoS Negl Trop Dis 2013; 7:e2225. [PMID: 23675551 PMCID: PMC3649971 DOI: 10.1371/journal.pntd.0002225] [Citation(s) in RCA: 64] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/08/2013] [Accepted: 04/08/2013] [Indexed: 11/18/2022] Open
Abstract
The incidence of clinical and clinicopathological signs associated with the progression of infection was evaluated prospectively in 329 naïve young dogs exposed to Leishmania infantum transmission and examined periodically during 22 months (M). The dogs were part of Leishmania vaccine investigations performed under natural conditions. Vaccinated groups were considered in the evaluation when the vaccine resulted non-protective and the appearance and progression of signs did not differ statistically from controls at each time point, otherwise only control groups were included. 115 beagles were part of 3 studies (A to C) performed in the same kennel; 214 owned dogs (29 breeds, 2.3% beagles) were included in a study (D) performed in 45 endemic sites. At M22 the prevalence of any Leishmania infection stage classified as subpatent, active asymptomatic, or symptomatic was 59.8% in studies A-C and 29.2% in study D. Despite different breed composition and infection incidence, the relative proportion of active infections and the progression and type of clinical and clinicopathological signs have been similar in both study sets. All asymptomatic active infections recorded have invariably progressed to full-blown disease, resulting in 56 sick dogs at M22. In these dogs, lymph nodes enlargement and weight loss--recorded from M12--were the most common signs. Cutaneous signs were seen late (M18) and less frequently. Ocular signs appeared even later, being sporadically recorded at M22. Most clinicopathological alterations became evident from M12, although a few cases of thrombocytopenia or mild non-regenerative anemia were already observed at M6. Albumin/globulin inversions were recorded from M12 and urea/creatinine increase appeared mostly from M18. Altogether our findings indicate that any susceptible young dogs naturally infected by L. infantum present a common pattern of progression of signs during 2 years post infection, providing clues for medical and epidemiological applied aspects.
Collapse
Affiliation(s)
| | - Trentina Di Muccio
- Unit of Vector-borne Diseases and International Health, MIPI Department, Istituto Superiore di Sanità, Rome, Italy
| | - Sivia Cappiello
- Department of Veterinary Clinical Sciences, University Federico II, Naples, Italy
| | - Aldo Scalone
- Unit of Vector-borne Diseases and International Health, MIPI Department, Istituto Superiore di Sanità, Rome, Italy
| | - Rosa Paparcone
- Department of Veterinary Clinical Sciences, University Federico II, Naples, Italy
| | - Eleonora Fiorentino
- Unit of Vector-borne Diseases and International Health, MIPI Department, Istituto Superiore di Sanità, Rome, Italy
| | - Manuela Gizzarelli
- Department of Veterinary Clinical Sciences, University Federico II, Naples, Italy
| | - Marina Gramiccia
- Unit of Vector-borne Diseases and International Health, MIPI Department, Istituto Superiore di Sanità, Rome, Italy
| | - Luigi Gradoni
- Unit of Vector-borne Diseases and International Health, MIPI Department, Istituto Superiore di Sanità, Rome, Italy
- * E-mail:
| | - Gaetano Oliva
- Department of Veterinary Clinical Sciences, University Federico II, Naples, Italy
| |
Collapse
|
24
|
Tánczos B, Balogh N, Király L, Biksi I, Szeredi L, Gyurkovsky M, Scalone A, Fiorentino E, Gramiccia M, Farkas R. First record of autochthonous canine leishmaniasis in Hungary. Vector Borne Zoonotic Dis 2012; 12:588-94. [PMID: 22607079 DOI: 10.1089/vbz.2011.0906] [Citation(s) in RCA: 31] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Hungary is traditionally regarded as a leishmaniasis-free country, and human or canine cases diagnosed locally have been recorded as imported. However, recent entomological surveys have verified the presence in Hungary of Phlebotomus neglectus and Phlebotomus perfiliewi perfiliewi, which have been incriminated as competent vectors of Leishmania infantum elsewhere in Europe. Following the occurrence in October 2007 of an undisputable clinical case of L. infantum canine leishmaniasis (CanL) in a 4-year-old female pug in a kennel of 20 dogs in Tolna province, an investigation was performed to assess the infection status in that canine population and to search for putative phlebotomine vectors. Another female pug became sick during the study period (May-November 2008) and L. infantum was confirmed as the causative agent. The other animals appeared clinically healthy; however, 4 additional dogs were found positive by indirect fluorescent antibody test (2 dogs), or by buffy-coat PCR (1 dog), or by both methods (1 dog). Hence the overall Leishmania infection prevalence in the kennel was 30% (6/20). All dogs were born in the same place and had been always kept outdoors. They had neither been abroad nor received a blood transfusion. No sand flies were collected with CDC Standard Miniature Light traps, Mosquito Magnet(®) X (MMX) dry ice-baited traps, or sticky traps placed either in or around the kennel and at nearby chicken yards during July and August of 2008 and 2009. Considering the dogs' historical background and the failure to trap any sand fly vectors in the kennel area, the origin of CanL in this site remains unexplained.
Collapse
Affiliation(s)
- Balázs Tánczos
- Department of Parasitology and Zoology, Faculty of Veterinary Science, Szent István University, Budapest, Hungary
| | | | | | | | | | | | | | | | | | | |
Collapse
|
25
|
Fabbian F, Pala M, De Giorgi A, Scalone A, Molino C, Portaluppi F, Mikhailidis DP, Manfredini R. Clinical features of cardio-renal syndrome in a cohort of consecutive patients admitted to an internal medicine ward. Open Cardiovasc Med J 2011; 5:220-5. [PMID: 22207887 PMCID: PMC3242402 DOI: 10.2174/1874192401105010220] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/22/2011] [Accepted: 10/13/2011] [Indexed: 11/22/2022] Open
Abstract
Introduction: Cardiorenal syndrome (CRS) is a disorder of the heart and kidney whereby interactions between the 2 organs can occur. We recorded the clinical features of CRS in patients consecutively admitted to an Internal Medicine ward. Patients and Methods: We retrospectively analyzed the anthropometric, history, clinical, biochemical and treatment characteristics in 438 out of 2,998 subjects (14.6%) admitted to our unit (from June 2007 to December 2009), diagnosed with CRS, according to Acute Dialysis Quality Initiative (ADQI) recommendations. Estimated glomerular filtration (eGFR) was calculated using several equations: MDRD (Modification of Diet in Renal Disease; 2 variations GFRMDRD186, GFRMDRD175), Mayo, Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) and Cockroft-Gault. Results: Mean age was 80±8 years, 222 (50.6%) were males, 321 (73.2%) were smokers, 229 (52.2%) were diabetic, 207 (47.2%) had a history of acute myocardial infarction, 167 (38.1%) had angina, 135 (30.8%) were affected by cerebrovascular disease, 339 (77.3%) had peripheral arterial disease. CRS was type 1 in 211 cases (48.2%), type 2 in 96 (21.9%), type 3 in 88 (20.1%), type 4 in 29 (6.6%) and type 5 in 14 (3.2%). eGFR, calculated by different formulae, ranged between 31 and 36 ml/min/1.73 m2. GFR was lower in CRS type 3 than in the other types, and the values ranged between 24 and 27 ml/min/1.73 m2. Mean hospital length-of-stay (LOS) was 9.8±6.3 days. Diuretics were the most prescribed medication (78.7%); only 5 patients underwent haemodialysis. Conclusions: CRS is common, especially in the elderly. CRS Type 1 was the prevalent subset and patients had stage 3-4 renal insufficiency. Results obtained from the GFR equations were similar although the Mayo equation tended to overestimate the eGFR.
Collapse
Affiliation(s)
- F Fabbian
- Clinica Medica, Department of Internal Medicine, University Hospital, Ferrara, Italy
| | | | | | | | | | | | | | | |
Collapse
|
26
|
Valgimigli M, Campo G, Tebaldi M, Monti M, Gambetti S, Scalone A, Parrinello G, Ferrari R. Randomized, double-blind comparison of effects of abiciximab bolus only vs. on-label regimen on ex vivo inhibition of platelet aggregation in responders to clopidogrel undergoing coronary stenting. J Thromb Haemost 2010; 8:1903-11. [PMID: 20586923 DOI: 10.1111/j.1538-7836.2010.03972.x] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
BACKGROUND On top of aspirin, an abciximab bolus-only regimen results in a 30% drop in platelet inhibition at 6 h as compared with the on-label regimen. The concomitant administration of high loading dose clopidogrel, by bridging with abciximab bolus, may sustain suppression of platelet activity over time. OBJECTIVES To investigate the non-inferiority of abciximab bolus-only and concomitant high loading dose clopidogrel vs. abciximab bolus + infusion with respect to the inhibition of platelet aggregation (IPA) as determined by light transmission aggregometry. PATIENTS/METHODS Seventy-three patients with non-ST segment elevation acute coronary syndromes underwent double-blind randomization to abciximab bolus followed by a 12-h placebo infusion and concomitant 600-mg clopidogrel vs. abciximab bolus + a 12-h infusion and 300 mg of clopidogrel. IPA was determined by light transmission aggregometry throughout 24 h. Clopidogrel poor responsiveness was defined as ≥ 50% 5 μmol L⁻¹ ADP-induced maximum platelet aggregation. RESULTS In clopidogrel responders (n = 68), IPA after 20 μmol L⁻¹ ADP at 4 h was 89% ± 13% in the bolus-only arm vs. 92% ± 14% in the bolus + infusion arm (P = 0.011 for non-inferiority). IPA after 5 or 20 μmol L⁻¹ ADP and 5 or 15 μmol L⁻¹ TRAP and the proportion of patients showing ≥ 80% IPA did not differ at any time point, irrespective of clopidogrel responsiveness status. Thirty-day outcomes were similar, whereas hemoglobin (0.91 ± 0.8 vs. 0.5 ± 0.7 g dL⁻¹ ; P = 0.01) and platelet count mean drop (41.7 ± 57 vs. 18.6 ± 34 10⁹ L⁻¹; P = 0.042) were significantly reduced in the bolus-only arm. CONCLUSIONS Withholding abciximab post-bolus infusion in patients receiving high loading dose clopidogrel does not impair platelet inhibition throughout 24 h, and has the potential to improve the safety profile of the drug at reduced costs.
Collapse
Affiliation(s)
- M Valgimigli
- Institute of Cardiology, University of Ferrara, Ferrara, Italy.
| | | | | | | | | | | | | | | |
Collapse
|
27
|
Gramiccia M, Di Muccio T, Fiorentino E, Scalone A, Bongiorno G, Cappiello S, Paparcone R, Foglia Manzillo V, Maroli M, Gradoni L, Oliva G. Longitudinal study on the detection of canine Leishmania infections by conjunctival swab analysis and correlation with entomological parameters. Vet Parasitol 2010; 171:223-8. [PMID: 20409639 DOI: 10.1016/j.vetpar.2010.03.025] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/26/2010] [Revised: 03/08/2010] [Accepted: 03/15/2010] [Indexed: 10/19/2022]
Abstract
A longitudinal study was carried out on kennelled stray dogs in a canine leishmaniasis (CanL) endemic area, to evaluate early and late diagnostic performance of a non-invasive conjunctival swab (CS) nested (n)-PCR analysis for Leishmania detection in 2 cohorts of dogs, respectively. (A) Sixty-five IFAT- and CS n-PCR-negative dogs exposed to, and followed up once or twice a month during a full sand fly season (July-November 2008). In parallel, a sand fly survey was performed on site using standard sticky traps set twice a month, for a cumulative surface of 63 m(2). (B) Seventeen IFAT- and CS n-PCR-negative dogs found positive in July 2008 at the peripheral blood buffy-coat (BC) n-PCR. These dogs were examined again by BC n-PCR in September and November 2008, and before the subsequent transmission season (May 2009) along with CS n-PCR and IFAT. None of the cohort (A) dogs converted to positive CS n-PCR during the transmission season. Although approximately 2500 phlebotomine specimens were collected with peaks of 100-147 specimens/m(2) sticky trap, the cumulative density of the only proven CanL vector in the area (Phlebotomus perniciosus) was found to be very low (0.5/m(2)). All cohort (B) dogs remained substantially seronegative; BC n-PCR showed an intermittent positive trend during the period surveyed, resulting in 82% conversions to negative by the end of the study, in contrast with 71% conversions to positive at the CS n-PCR analysis. In conclusion, while CS n-PCR was not found effective for the early detection of Leishmania contacts in dogs exposed to a low pressure of vectorial transmission, this assay showed to slowly convert to positive in a high rate of dogs, in the absence of seroconversion. CS n-PCR technique can be a suitable marker for assessing Leishmania exposure in dogs as a non-invasive alternative to current serological and molecular tools.
Collapse
Affiliation(s)
- Marina Gramiccia
- Unit of Vector-borne Diseases & International Health, MIPI Department, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
28
|
Morosetti G, Bongiorno G, Beran B, Scalone A, Moser J, Gramiccia M, Gradoni L, Maroli M. Risk assessment for canine leishmaniasis spreading in the north of Italy. Geospat Health 2009; 4:115-127. [PMID: 19908194 DOI: 10.4081/gh.2009.214] [Citation(s) in RCA: 43] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/28/2023]
Abstract
The incidence of zoonotic visceral leishmaniasis has not only been recognized but is, in fact, increasing in territories of northern continental Italy previously regarded as non-endemic. Recent findings of sporadic autochthonous canine infections and the presence of phlebotomine vectors in some provinces of north-eastern Italy have stimulated risk assessment for the spreading of leishmaniasis in the autonomous province of Bolzano-South Tyrol, the northernmost territory of the Italian eastern Alps. In July 2008, 61 phlebotomine sand flies (Diptera, Psychodidae) were caught and identified as Phlebotomus perniciosus and Sergentomyia minuta. This is the first record in South Tyrol of P. perniciosus, the most competent vector of Leishmania infantum in Mediterranean countries. Leishmania serology on local dogs kept in kennels gave negative results, while only imported canine leishmaniasis cases were reported by local veterinaries through a questionnaire survey. Bio-geographic aspects and epidemiological consequences are analyzed in relation with the risk of leishmaniasis introduction into the area.
Collapse
Affiliation(s)
- Giulia Morosetti
- Veterinary Services of Bolzano, Health Department of South Tyrol, Italy
| | | | | | | | | | | | | | | |
Collapse
|
29
|
Daprà F, Scalone A, Mignone W, Ferroglio E, Mannelli A, Biglino A, Zanatta R, Gradoni L, Rosati S. Validation of a recombinant based antibody ELISA for diagnosis of human and canine leishmaniasis. J Immunoassay Immunochem 2008; 29:244-56. [PMID: 18569373 DOI: 10.1080/15321810802116006] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/11/2023]
Abstract
In this study, a recombinant chimeric antigen (CA) ELISA was validated as a single test for both human and dog leishmaniasis. Serum panels included 327 human and 339 canine IFAT-positive and 1113 human and 1078 canine IFAT-negative samples. CA-ELISA was carried out using the same serum dilution, and labelled protein A as secondary reagent. Test performances were calculated using ROC analysis. For the human panel, the test showed diagnostic accuracy (DA) 0.974, specificity (Sp) 97.12%, sensitivity (Se) 91.44%, and concordance (K) 0.88. The dog panel showed DA 0.998, Sp 99.54%, Se 98.54%, and K 0.98. The proposed method is the best recombinant antigen-based ELISA, and can be used as IFAT substitute for mass screening.
Collapse
Affiliation(s)
- Franco Daprà
- Department of Animal Production, Epidemiology and Ecology, Faculty of Veterinary Medicine, University of Torino, Via Leonardo da Vinci 44, 10095 Grugliasco (TO), Italy
| | | | | | | | | | | | | | | | | |
Collapse
|
30
|
Oliva G, Scalone A, Foglia Manzillo V, Gramiccia M, Pagano A, Di Muccio T, Gradoni L. Incidence and time course of Leishmania infantum infections examined by parasitological, serologic, and nested-PCR techniques in a cohort of naive dogs exposed to three consecutive transmission seasons. J Clin Microbiol 2006; 44:1318-22. [PMID: 16597857 PMCID: PMC1448675 DOI: 10.1128/jcm.44.4.1318-1322.2006] [Citation(s) in RCA: 150] [Impact Index Per Article: 8.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
Most experience in the comparison of diagnostic tools for canine leishmaniasis comes from cross-sectional surveys of dogs of different ages and breeds and in cases with unknown onset and duration of leishmaniasis. A longitudinal study was performed on 43 beagle dogs exposed to three transmission seasons (2002 to 2004) of Mediterranean leishmaniasis and examined periodically over 32 months through bone marrow microscopy and nested PCR (n-PCR), lymph node culture, serology (immunofluorescent-antibody test), and evaluation of clinical parameters. Starting from January 2003, the highest rate of positives was detected by n-PCR at all assessments (from 23.3% to 97.3%). Sensitivities of serologic and parasitological techniques were lower but increased with time, from 15.8% to 75.0 to 77.8%. Some dogs that tested positive by n-PCR but negative by other tests ("subpatent infection") remained so until the end of the study or converted to negative in subsequent assessments, whereas all dogs with positive serology and/or microscopy/culture ("asymptomatic patent infection") exhibited progressive leishmaniasis; 68% of them developed clinical disease ("symptomatic patent infection") during the study, at 7 (range, 3 to 14) months after being positive to all tests. Postexposure infection incidences were high and were significantly different between 2002 and 2003 exposures (39.5% and 91.7%, respectively). The time course of infection was highly variable in each dog, with three patterns being identified: (i) rapid establishment of a patent condition (0 to 2 months from detection of infection); (ii) a prolonged subpatent condition (4 to 22 months) before progression; and (iii) a transient subpatent condition followed by 10 to 21 months of apparent Leishmania-negative status before progression.
Collapse
Affiliation(s)
- Gaetano Oliva
- Unit of Vector-borne Diseases & International Health, MIPI Department, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy
| | | | | | | | | | | | | |
Collapse
|
31
|
Boarino A, Scalone A, Gradoni L, Ferroglio E, Vitale F, Zanatta R, Giuffrida MG, Rosati S. Development of recombinant chimeric antigen expressing immunodominant B epitopes of Leishmania infantum for serodiagnosis of visceral leishmaniasis. Clin Diagn Lab Immunol 2005; 12:647-53. [PMID: 15879027 PMCID: PMC1112073 DOI: 10.1128/cdli.12.5.647-653.2005] [Citation(s) in RCA: 60] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
Wild canids and domestic dogs are the main reservoir of zoonotic visceral leishmaniasis (VL) caused by Leishmania infantum (syn.: Leishmania chagasi). Serological diagnosis of VL is therefore important in both human and dog leishmaniasis from a clinical and epidemiological point of view. Routine diagnosis of VL is traditionally carried out by immunofluorescent antibody test (IFAT), which is laborious and difficult to standardize and to interpret. In the last decade, however, several specific antigens of Leishmania infantum have been characterized, allowing the development of a recombinant-based immunoassay. Among them, the whole open reading frame encoding K9 antigen, the gene fragment encoding the repetitive sequence of K26, and the 3'-terminal gene fragment of the kinesin-related protein (K39sub) were previously evaluated as diagnostic markers for canine leishmaniasis and proved to be independent in their antibody reactivity. Since sensitivity of serological test is usually higher in multiple-epitope format, in this study the relevant epitopes of K9, K26, and K39 antigens were joined by PCR strategy to produce the chimeric recombinant protein. The resulting mosaic antigen was found highly expressed in Escherichia coli and efficiently purified by affinity chromatography. Antigenic properties of this recombinant antigen were evaluated by indirect enzyme-linked immunosorbent assay (ELISA) using a panel of human and dog sera previously characterized by parasitological and/or serological techniques. Chimeric ELISA showed 99% specificity in both human (n = 180) and canine (n = 343) control groups, while sensitivity was higher in canine VL (96%, n = 213) than in human VL (82%, n = 185). Accordingly, concordance between IFAT and canine chimeric ELISA (k = 0.95, 95% confidence interval = 0.93 to 0.98) was higher than between IFAT and human chimeric ELISA (k = 0.81, 95% confidence interval = 0.76 to 0.87). Results suggest the potential use of this new antigen for routine serodiagnosis of VL in both human and canine hosts.
Collapse
Affiliation(s)
- A Boarino
- Dipartimento di Produzioni Animali, Epidemiologia ed Ecologia, Facoltà di Medicina Veterinaria, Via Leonardo da Vinci 44, 10095 Grugliasco (TO) Italy.
| | | | | | | | | | | | | | | |
Collapse
|
32
|
Gradoni L, Foglia Manzillo V, Pagano A, Piantedosi D, De Luna R, Gramiccia M, Scalone A, Di Muccio T, Oliva G. Failure of a multi-subunit recombinant leishmanial vaccine (MML) to protect dogs from Leishmania infantum infection and to prevent disease progression in infected animals. Vaccine 2005; 23:5245-51. [PMID: 16054272 DOI: 10.1016/j.vaccine.2005.07.001] [Citation(s) in RCA: 94] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/28/2005] [Accepted: 07/01/2005] [Indexed: 11/19/2022]
Abstract
We report results of a Phase III trial of the multi-subunit recombinant Leishmania polyprotein MML for the protection of dogs against infection by Leishmania infantum. The antigen, also known as Leish-111f, is the first antileishmanial human vaccine entered Phase I clinical testing. The study was performed in a leishmaniasis endemic area of southern Italy. Three groups of 15 Leishmania-free beagle dogs each, received 3 monthly injections with vaccines A (MML+MPL-SE adjuvant), B (sterile saline = control) and C (MML+Adjuprime adjuvant), respectively, before transmission season 2002. The surviving dogs received a second three-dose vaccine course 1 year later. The dogs were naturally exposed to sandfly bites for 2.5 months in 2002, and for 5 months in 2003. Every 2 months post vaccination, dogs were examined by clinical and immunological evaluation, and by specific serology, microscopy, culture and PCR. A weak lymphoproliferative response to MML was seen in A and C groups throughout the study period. One year after the first vaccine course, the cumulative incidence of leishmanial infections was 40% in group A, 43% in group B and 36% in group C. Two-year post-vaccination (1 year after the second vaccine course) the cumulative incidence was 87% in group A (with three symptomatic cases), 100% in group B (with no symptomatic cases) and 100% in group C (with two symptomatic cases). The efficacy of the MML vaccine as an immunotherapeutic agent for the prevention of disease progression (subpatent infection-->asymptomatic patent infection-->symptomatic patent infection) was evaluated through follow-up of dogs found infected prior to the second vaccination. Among 15 infected animals, progression to a subsequent stage of infection was found in 5/6 dogs of group A, 3/6 of group B and 2/3 of group C. We conclude that vaccination with MML is not effective to prevent leishmaniasis infection and disease progression in dogs under field conditions.
Collapse
Affiliation(s)
- L Gradoni
- Dipartimento di Malattie Infettive, Parassitarie e Immunomediate, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Roma, Italy.
| | | | | | | | | | | | | | | | | |
Collapse
|
33
|
di Martino L, Gramiccia M, Occorsio P, Di Muccio T, Scalone A, Gradoni L. [Infantile visceral leishmaniasis in the Campania region, Italy: experience from a Paediatric Referral Centre]. Parassitologia 2004; 46:221-3. [PMID: 15305721] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/30/2023]
Abstract
In the first half of the 20th century, visceral leishmaniasis (VL) was a common infantile syndrome in coastal territories of the Campania region of Italy. After World War II, the incidence dropped to a few cases/year for three decades; in late 1980s the disease reemerged among both children and adults. To face the VL recrudescence, a Paediatric Reference Centre was established at the Santobono-Pausilipon hospital in Naples, for the clinical diagnosis, care and drug treatment of all infantile VL cases occurred in the Campania region. Rapid laboratory diagnosis was secured by a Diagnostic Reference Centre established at the Istituto Superiore di Sanità. Here, we report on the epidemiological and parasitological features of all cases referred to the Centre in the past 15 years. From 1990 to March 2004, a total of 255 cases were diagnosed and treated at the Centre. The Figure shows the yearly trend of patients (min. 3 cases in 1990 and 1991, max. 30 cases in 2000). There were 135 males (52.9%); the age ranged 4 months-14 years, but 189 patients (74.1%) were < or = 3 years old. The majority of the patients (189, 74.1%) were from the Naples province, with a cluster of 102 cases (40% of total patients) from the towns and districts surrounding Vesuvius. Twenty-seven cases (10.6%) were from the town of Maddaloni, Caserta province, whereas 15 cases (5.9%) were from coastal villages of the Salerno province. Only 1 and 2 cases were from Benevento and Avellino provinces, respectively. All patients but seven, who have been treated with antimonial drugs in the 1990-1993 period, were successfully treated with a liposomal amphotericin B regimen. From bone-marrow aspirate samples, 138 Leishmania cultures were obtained in EMTM and Sloppy Evans' media, of which 134 have been typed by the electrophoretic analysis of 13 isoenzymes. Two zymodemes (Z) of L. infantum were routinely identified over the study period, ZMON-1 (the commonest zymodeme in the Mediterranean area) and ZMON-72, variant from MON-1 in PGM mobility and detected only in our region. The latter, identified in 61 patients (45.5%), was found exclusively distributed in towns of the Vesuvius area and in Maddaloni until 1996, but in recent years it appears to have spread to other areas of the Naples (including the island of Ischia) and Caserta provinces, but not to Salerno province. In conclusion, the VL macrofocus of the Naples-Caserta area is probably responsible for the highest number of infantile cases among any VL macrofoci described in southern Europe. Considering the limited efforts paid to control the canine reservoir, rapid diagnosis and appropriate treatment of patients still remain the first-line control measures aimed at reducing the health impact of the disease.
Collapse
Affiliation(s)
- L di Martino
- Centro Regionale di Riferimento per la Leishmaniosi Viscerale Pediatrica, Dipartimento di Pediatria, Ospedale Santobono, Napoli, Italy
| | | | | | | | | | | |
Collapse
|
34
|
Gradoni L, Gramiccia M, Scalone A. [Change in human visceral leishmaniasis treatment in Italy: retrospective study of 630 patients]. Parassitologia 2004; 46:199-201. [PMID: 15305716] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/30/2023]
Abstract
Since the 1940s meglumine antimoniate (MA) has been the only first-line drug for visceral leishmaniasis (VL) treatment in Italy. From 1991 through 1994, several patients of all ages, representing 1/3 of all immunocompetent VL patients reported during that period, were enrolled in clinical trials of liposomal amphotericin B (L-AmB), which led to a novel, safe, short course of VL treatment as an alternative to MA. In the same period, other lipid-associated AmB drugs were registered in Italy for the treatment of fungal infections, i.e., AmB colloidal dispersion (ABCD) and AmB lipid complex (ABLC). A retrospective analysis was performed on data collected at the Unit of Protozoology of Istituto Superiore di Sanità, Rome, to assess whether changes have occurred in first-line drug regimens adopted in Italy for routine VL treatment, during the 1995-2002 period. The sample consisted of immunocompetent individuals clinically suspected for VL, in whom the disease was confirmed by the examination of serum and bone marrow specimens sent to the Unit by hospitals from throughout the country. Relevant information on patients was then recorded, which included drug regimens used and post-therapy results. We recorded treatment information for 630 patients, representing a large proportion (55.5%) of 1,135 immunocompetent individuals with VL reported in Italy from 1995 through 2002. About half were children (306). Every year, patients were referred by 19 to 42 hospitals, with a range of 1 to 30 patients per hospital. MA was the first-line drug used in 159 patients (25.2%). However, the proportion of MA-treated patients has steadily decreased from 55.9% in 1995 to 1.0% in 2002. We recorded the failure of MA therapy in 16 patients (10.1%), who were successfully retreated with a L-AmB regimen. The rate of MA failures significantly increased in recent years, from 5.3% in 1995 to 36.4% in 2000 (p = 0.01). AmB drugs have been the only alternative drugs used in the remaining 471 patients (74.8%). L-AmB accounted for most regimens (441, 93.6%). The proportion of patients treated with any AmB-based drugs increased from 44.1% in 1995 to 99.0% in 2002. Drug treatment was unsuccessful in 15 patients (3.2%), who were successfully retreated with a high-dose L-AmB regimen. This rate was significantly lower than the MA failure rate (p = 0.001). Results have shown a countrywide change in therapy over the period considered. A traditionally effective, but moderately toxic drug (MA) has been almost fully replaced by a new compound (L-AmB) with negligible toxicity, in an epidemiologic context of disease reemergence. Furthermore, short courses of 6 to 7 days, as required for lipid-associated AmB, are highly cost-effective if compared with 21- to 28-day courses needed for standard MA treatment.
Collapse
Affiliation(s)
- L Gradoni
- Reparto di Malattie Trasmesse da Vettori e Sanità Internazionale, Dipartimento MIPI, Istituto Superiore di Sanità, Roma, Italy
| | | | | |
Collapse
|
35
|
Abstract
First-line drug treatment was recorded in 573 immunocompetent patients with visceral leishmaniasis in Italy. In the past 12 years, the proportion of antimonial treatments decreased from 100% to 2.8%, while the proportion of amphotericin B treatments increased from 0% to 97.2%. The countrywide change in therapy is a response to both disease reemergence and increasing antimonial failure.
Collapse
Affiliation(s)
- Luigi Gradoni
- Laboratorio di Parassitologia, Istituto Superiore di Sanità, Rome, Italy.
| | | | | |
Collapse
|
36
|
Pagliano P, Rossi M, Rescigno C, Altieri S, Coppola MG, Gramiccia M, Scalone A, Gradoni L, Faella F. Mediterranean visceral leishmaniasis in HIV-negative adults: a retrospective analysis of 64 consecutive cases (1995-2001). J Antimicrob Chemother 2003; 52:264-8. [PMID: 12865389 DOI: 10.1093/jac/dkg340] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
AIM To evaluate in a retrospective analysis cases of Mediterranean visceral leishmaniasis (VL) diagnosed in HIV-negative adults during a 7-year period. MATERIALS AND METHODS Demographic data, previous or underlying diseases, clinical and laboratory features and therapeutic findings were considered. RESULTS A total of 64 patients were included, of whom 10 (16%) had underlying diseases and two were pregnant. Fever and hepatosplenomegaly were the main presenting symptoms, whereas pancytopenia and an elevated erythrocyte sedimentation rate were observed in all cases. Smears from bone marrow aspirate were positive at microscopy in 62 cases (97%). Twenty-four patients received meglumine antimoniate (MA) given during 21 consecutive days (20 mg/kg per day), and 40 patients liposomal amphotericin B (l-AmB) given at days 1-5 and 10 (3 mg/kg per day). Both groups' clinical and laboratory findings improved, but patients on l-AmB therapy had a faster recovery (85% on l-AmB therapy and 50% on MA therapy showed defervescence at day 5, P < 0.01). Treatment failures were observed in five cases, three (12%) on MA and two (5%) on l-AmB therapy. No significant toxicity was observed in patients treated with l-AmB, whereas three (12%) patients treated with MA showed electrocardiographic abnormalities. CONCLUSIONS l-AmB therapy may be considered the treatment of choice for any adult patients with Mediterranean VL, since it permits a faster recovery, has a lower incidence of side effects and is useful also in immunosuppressed patients.
Collapse
Affiliation(s)
- Pasquale Pagliano
- I Division of Infectious Disease, D. Cotugno Hospital, Naples, Italy.
| | | | | | | | | | | | | | | | | |
Collapse
|
37
|
Scalone A, De Luna R, Oliva G, Baldi L, Satta G, Vesco G, Mignone W, Turilli C, Mondesire RR, Simpson D, Donoghue AR, Frank GR, Gradoni L. Evaluation of the Leishmania recombinant K39 antigen as a diagnostic marker for canine leishmaniasis and validation of a standardized enzyme-linked immunosorbent assay. Vet Parasitol 2002; 104:275-85. [PMID: 11836028 DOI: 10.1016/s0304-4017(01)00643-4] [Citation(s) in RCA: 74] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
Abstract
Canine infections with Leishmania infantum are important as a cause of serious disease in the dog and as a reservoir for human visceral leishmaniasis (VL). Accurate diagnosis of canine infections is essential to the veterinary community and for VL surveillance programs. A standardized ELISA using a purified recombinant antigen (rK39) specific to VL was compared to the immunofluorescent antibody test (IFAT) as the standard. The ELISA was developed, optimized and evaluated using sera from 6368 dogs. The standardized ELISA and IFAT results were highly concordant. The timing and pattern of ELISA and IFAT seroconversion in dogs followed prospectively after natural infections were very similar. Antibodies reacting with rK39 were more common in asymptomatic canine infections than reported for subclinical human VL. The rK39 ELISA is a relatively simple and rapid assay for assessing the infection status of dogs, and is an alternative to IFAT, especially when screening large numbers of samples.
Collapse
Affiliation(s)
- A Scalone
- Laboratorio di Parassitologia, Istituto Superiore di Sanità, Rome, Italy
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
38
|
Gaeta GB, Maisto A, Di Caprio D, Scalone A, Pasquale G, Felaco FM, Galante D, Gradoni L. Efficacy of amphotericin B colloidal dispersion in the treatment of Mediterranean visceral leishmaniasis in immunocompetent adult patients. Scand J Infect Dis 2002; 32:675-7. [PMID: 11200380 DOI: 10.1080/003655400459612] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/16/2022]
Abstract
Twelve immunocompetent adults with Mediterranean visceral leishmaniasis (VL) were treated with amphotericin B colloidal dispersion (ABCD; 2 mg/kg/d for 7 d). All patients showed rapid clinical response without significant adverse events. Two weeks after therapy they were parasitologically cured and no relapses occurred during 6 months. ABCD is a valid alternative in the management of Mediterranean VL in adult patients.
Collapse
Affiliation(s)
- G B Gaeta
- Dipartimento di Malattie Infettive, Seconda Università, Naples, Italy
| | | | | | | | | | | | | | | |
Collapse
|
39
|
Barbieri S, Michieletto E, Feltracco P, Meroni M, Salvaterra F, Scalone A, Gasparetto M, Pengo G, Cacciani N, Lodi G, Giron GP. [Prognostic systems in intensive care: TRISS, SAPS II, APACHE III]. Minerva Anestesiol 2001; 67:519-38. [PMID: 11602872] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/21/2023]
Abstract
BACKGROUND To validate the accuracy of SAPS II, APACHE III and TRISS for the prediction of mortality in Intensive Care Unit (ICU) at polytrauma patients admission. The outcome of multiple trauma patients is often linked to the degree of physiologic dysfunction and to the extension of anatomic lesions, the age of the patient and the lesion mechanism. METHODS The study population consisted of 93 cases of multiple injured patients hospitalised at the ICU of the Padua hospital from October 1998 to October 1999; the term polytraumatized patient is referred to patients who have multiple lesions of which at least one potentially endangers, immediately or in a short term, their life. These cases were evaluated with the APACHE III, SAPS II, Revised Trauma Score and Injury Severity Score. The predictive power of each system was evaluated by using decision matrix analysis to compare observed and predicted outcome with a decision criterion of 0.50 and 0.40 for risk of hospital death. RESULTS All trauma score systems under study showed high accuracy rates, above all if they are used with a 40% positive test. CONCLUSIONS The prognostic scales used in this study showed a good correlation between expected and observed cases, particularly with TRISS and APACHE III systems. The APACHE III system seems to be the most reliable of the different methods analysed. These prognostic systems are seldom or occasionally used in the ICU, in Padua and in the whole of Italy, so Italian data are not suitable to be compared to international ones. Due to urgency, the importance of the evaluation scales is often underestimated, but even if they require time and attention, they surely can be useful in the evaluation of the treatment, and not only of a polytraumatized patient.
Collapse
Affiliation(s)
- S Barbieri
- Dipartimento di Farmacologia ed Anestesiologia, Egidio Meneghetti, Sede di Anestesiologia e Rianimazione, Università degli Studi, Padova, Italy
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
40
|
Barbieri S, Michieletto E, Di Giulio M, Feltracco P, Gorlato P, Salvaterra F, Scalone A, Spagna A. Prehospital airway management with the laryngeal mask airway in polytraumatized patients. PREHOSP EMERG CARE 2001; 5:300-3. [PMID: 11446550 DOI: 10.1080/10903120190939869] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Affiliation(s)
- S Barbieri
- Department of Pharmacology and Anaesthesiology E Meneghetti, OU Anaesthesia and Intensive Care, University of Padua, Italy
| | | | | | | | | | | | | | | |
Collapse
|
41
|
Salvati L, Mattu M, Colasanti M, Scalone A, Venturini G, Gradoni L, Ascenzi P. NO donors inhibit Leishmania infantum cysteine proteinase activity. Biochim Biophys Acta 2001; 1545:357-66. [PMID: 11342060 DOI: 10.1016/s0167-4838(00)00297-1] [Citation(s) in RCA: 42] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
Nitric oxide (NO) releasing drugs (e.g., glyceryl trinitrate) were successfully used in the treatment of cutaneous leishmaniasis in man. In the present study, the effect of NO donors on the catalytic activity of the cysteine proteinase from promastigotes of Leishmania infantum, an agent of Old World visceral and cutaneous leishmaniases, is reported. In particular, one equivalent of NO, released by the NO donors S-nitrosoglutathione, glyceryl trinitrate, (+/-)-(E)-4-ethyl-2-[(E)-hydroxyimino]-5-nitro-3-hexenamide, 3-morpholinosydnonimine, S-nitrosoacetylpenicillamine and sodium nitroprusside, inhibited one equivalent of the parasite cysteine proteinase. As expected, NO-deprived compounds did not affect the catalytic activity of the parasite cysteine proteinase. Furthermore, the absorption spectrum of the (+/-)-(E)-4-ethyl-2-[(E)-hydroxyimino]-5-nitro-3-hexenamide-treated inactive L. infantum enzyme displayed a maximum in the 330-350 nm wavelength range. The reducing agents dithiothreitol and L-ascorbic acid completely prevented parasite cysteine proteinase inhibition by NO, fully restored the catalytic activity, and reversed the NO-induced absorption spectrum of the inactive enzyme. Moreover, S-nitrosoacetylpenicillamine displayed a leishmanicidal effect, inhibiting the cysteine proteinase activity in vivo. As expected, the NO-deprived compound N-acetylpenicillamine did not affect significantly the parasite viability and the enzyme activity in vivo. These data suggest that the L. infantum cysteine proteinase undergoes NO-mediated S-nitrosylation, thereby representing a possible mechanism of antiparasitic host defence.
Collapse
Affiliation(s)
- L Salvati
- Dipartimento di Biologia, Università "Roma Tre", Rome, Italy
| | | | | | | | | | | | | |
Collapse
|
42
|
De Luna R, Vuotto ML, Ielpo MT, Ambrosio R, Piantedosi D, Moscatiello V, Ciaramella P, Scalone A, Gradoni L, Mancino D. Early suppression of lymphoproliferative response in dogs with natural infection by Leishmania infantum. Vet Immunol Immunopathol 1999; 70:95-103. [PMID: 10507290 DOI: 10.1016/s0165-2427(99)00073-2] [Citation(s) in RCA: 31] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Dogs are the domestic reservoirs of zoonotic visceral leishmaniasis caused by Leishmania infantum. Early detection of canine infections evolving to clinically patent disease may be important to leishmaniasis control. In this study we firstly investigated the peripheral blood mononuclear cell (PBMC) response to leishmanial antigens and to polyclonal activators concanavalin A, phytohemagglutinin and pokeweed mitogen, of mixed-breed dogs with natural L. infantum infection, either in presymptomatic or in patent disease condition, compared to healthy animals. Leishmania antigens did not induce a clear proliferative response in any of the animals examined. Furthermore, mitogen-induced lymphocyte proliferation was found strongly reduced not only in symptomatic, but also in presymptomatic dogs suggesting that the cell-mediated immunity is suppressed in progressive canine leishmaniasis. To test this finding, naive Beagle dogs were exposed to natural L. infantum infection in a highly endemic area of southern Italy. Two to 10 months after exposure all dogs were found to be infected by Leishmania, and on month 2 of exposure they all showed a significant reduction in PBMC activation by mitogens. Our results indicate that suppression of the lymphoproliferative response is a common occurrence in dogs already at the beginning of an established leishmanial infection.
Collapse
Affiliation(s)
- R De Luna
- Istituto di Clinica Medica Veterinaria, Università Federico II, Naples, Italy
| | | | | | | | | | | | | | | | | | | |
Collapse
|
43
|
Houghton RL, Petrescu M, Benson DR, Skeiky YA, Scalone A, Badaró R, Reed SG, Gradoni L. A cloned antigen (recombinant K39) of Leishmania chagasi diagnostic for visceral leishmaniasis in human immunodeficiency virus type 1 patients and a prognostic indicator for monitoring patients undergoing drug therapy. J Infect Dis 1998; 177:1339-44. [PMID: 9593022 DOI: 10.1086/515289] [Citation(s) in RCA: 64] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
Abstract
Serologic assays using crude antigens for the diagnosis of visceral leishmaniasis in human immunodeficiency virus type 1 (HIV)-seropositive patients have been shown to lack sensitivity and specificity, particularly in AIDS patients. Antibodies to a cloned antigen, recombinant (r) K39, of Leishmania chagasi are specific for members of the Leishmania donovani complex and have been shown to indicate active disease in immunocompetent persons. This study demonstrated that antibodies to rK39 were also detectable in HIV-seropositive patients coinfected with Leishmania infantum. Furthermore, the rK39 ELISA was more sensitive than an IFA for detecting L. infantum infections in patients with AIDS. In addition, antibody titers to rK39 in HIV-negative patients infected with L. infantum or L. chagasi declined during treatment with meglumine antimoniate or liposomal amphotericin B. In contrast, most patients who clinically relapsed showed increased antibody titers to rK39. These data demonstrate the diagnostic and prognostic utility of rK39 in detecting active visceral leishmaniasis.
Collapse
|
44
|
Oliva G, Gradoni L, Cortese L, Orsini S, Ciaramella P, Scalone A, de Luna R, Persechino A. Comparative efficacy of meglumine antimoniate and aminosidine sulphate, alone or in combination, in canine leishmaniasis. Ann Trop Med Parasitol 1998; 92:165-71. [PMID: 9625912 DOI: 10.1080/00034989860003] [Citation(s) in RCA: 21] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
Thirty-two domestic dogs naturally infected with Leishmania infantum and showing viscero-cutaneous signs of canine leishmaniasis were treated with aminosidine sulphate (11 dogs) meglumine antimoniate (10 dogs) or with a combination of the two drugs (11 dogs) for 21 consecutive days. Clinical and laboratory assessments, made on day 21 and at 2, 4 and 6 months after initiation of treatment, showed that the drug combination gave the best score in terms of clinical efficacy, incidences of early clinical relapse, any clinical relapse or apparent parasitological cure, and reduction in parasite densities in bone-marrow and lymphnode aspirates (even though a lower dose of antimonial was used in the combination than for antimonial monotherapy). For each of the above parameters, however, the higher efficacy of the drug combination was not statistically significant, probably because of the large variations caused by using naturally infected animals of various ages and breeds.
Collapse
Affiliation(s)
- G Oliva
- Instituto di Clinica Medica Veterinaria, Universitá Federico II, Naples, Italy
| | | | | | | | | | | | | | | |
Collapse
|
45
|
Abstract
A rare case of an AIDS patient who developed scattered necrotic involvement of the liver caused by Leishmania infantum is described. Of interest, marked splenomegaly, hypergammaglobulinemia and serum anti-Leishmania antibodies were absent and an incomplete response to therapy was observed. Diagnosis of visceral leishmaniasis (VL) was achieved by the demonstration of numerous amastigotes in both hepatocytes and macrophages on liver biopsy. Hepatic necrotic lesions, which when extensive could lead to acute hepatic failure, possibly reflect an atypical manifestation of liver involvement caused by L. infantum and depend on the immunological impairment which characterizes AIDS patients, thus preventing the formation of granulomas. Our observation confirms that VL can manifest atypical aspects in HIV-positive patients depending on the degree of the immunodeficiency. The frequency and severity of this pathology accounts for the need to list VL among AIDS-defining conditions.
Collapse
Affiliation(s)
- G Angarano
- Clinic of Infectious Disease and Institute of Hygiene of the University of Bari, Policlinico, Italy
| | | | | | | | | | | | | |
Collapse
|
46
|
Ciaramella P, Oliva G, Luna RD, Gradoni L, Ambrosio R, Cortese L, Scalone A, Persechino A. A retrospective clinical study of canine leishmaniasis in 150 dogs naturally infected by Leishmania infantum. Vet Rec 1997; 141:539-43. [PMID: 9413121 DOI: 10.1136/vr.141.21.539] [Citation(s) in RCA: 263] [Impact Index Per Article: 9.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
The clinical and laboratory findings observed in 150 dogs naturally infected by Leishmania infantum, from a large endemic area of southern Italy, are described. There was a gradual onset of clinical signs and the course of the disease was progressive in almost all the cases. The majority of the dogs were mongrels (43.3 per cent), male (64.7 per cent), of medium size (50.6 per cent), three to seven years old (64.7 per cent), and living outdoors (60 per cent). They showed generalised (56.7 per cent) or symmetrical (32 per cent) lymphadenomegaly; the mucous membranes of 87 of the dogs (58 per cent) were pale and moderate or severe splenomegaly was diagnosed in 80 dogs (53.3 per cent); weight loss was observed in 32 per cent of the animals. Skin abnormalities were very common, and included dry exfoliative dermatitis (56 per cent), ulcers (40 per cent) periorbital alopecia ('lunettes') (18 per cent), diffuse alopecia (14 per cent) and onychogryphosis (24 per cent). Ocular signs were observed in 24 dogs (16 per cent) including 16 cases of keratoconjunctivitis (three with keratoconjunctivitis sicca), six cases of moderate uveitis and two cases of panophthalmitis. The acute form of the disease was diagnosed in only six dogs and was characterised by fever and generalised lymphadenomegaly, and by the absence of skin lesions. Another six dogs had severe renal failure without systemic clinical signs of leishmaniasis. The most important laboratory findings were a severe or moderate increase in gammaglobulins, hypoalbuminaemia, hyperproteinemia and anaemia. Cultures or cytology tests for L infantum parasites were positive in 134 of the dogs. Following the standard procedures developed for human lymph node and bone marrow cytology tests, the leishmania density in the dogs varied from 1+ to 2+. Leishmania antibody titres were high (> 1:160) in almost all the dogs. Immunological tests for autoantibodies were positive in 25 of 53 dogs tested in the antinuclear antibody (ANA) test, in 15 of 43 dogs tested in the latex test and in five of 24 dogs tested in the Coombs test.
Collapse
Affiliation(s)
- P Ciaramella
- Istituto di Clinica Medica Veterinaria, Università Federico II, Napoli, Italy
| | | | | | | | | | | | | | | |
Collapse
|
47
|
Cascio A, Gradoni L, Scarlata F, Gramiccia M, Giordano S, Russo R, Scalone A, Camma C, Titone L. Epidemiologic surveillance of visceral leishmaniasis in Sicily, Italy. Am J Trop Med Hyg 1997; 57:75-8. [PMID: 9242323 DOI: 10.4269/ajtmh.1997.57.75] [Citation(s) in RCA: 33] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023] Open
Abstract
Visceral leishmaniasis (VL) is endemic in Sicily. Although it is a notifiable disease, there is evidence that the actual number of cases is higher than that reported. In 1987, a regional reference center for active surveillance of VL was established and it recorded a total of 284 cases through 1995, a mean of 31.5 cases/year and about four-fold more than previously reported. Of the 284 cases, 150 (53%) were children (< or = 14 years of age), and of the 134 adults, 39 (29%) were coinfected with human immunodeficiency virus (HIV). The commonest viscerotropic zymodeme of Leishmania infantum, MON 1, was identified in 40 (93%) of 43 HIV-negative and eight (57%) of 14 HIV-positive patients. Among 280 patients evaluated (i.e., all HIV-negative and 35 of 39 HIV-positive subjects), 254 (91%) were treated with meglumine antimoniate alone or in combination with other drugs; 23 (8%) received allopurinol or amphotericin B, either conventional or in liposomal form; and three terminally ill patients were not treated. Among the 245 HIV-negative patients, 236 (96%) were successfully cured, while nine (4%) (seven adults) died during the course of antimonial treatment. None of the 35 HIV-positive patients was definitively cured, although mortality was apparently associated with other opportunistic infections.
Collapse
Affiliation(s)
- A Cascio
- Istituto di Patologia Infettiva e Virologia, Università di Palermo, Italy
| | | | | | | | | | | | | | | | | |
Collapse
|
48
|
Castagnola E, Tasso L, Timitilli A, Scalone A, Giacchino R. Visceral leishmaniasis presenting as autoimmune hepatitis in a two years old boy. Trans R Soc Trop Med Hyg 1997; 91:28. [PMID: 9093621 DOI: 10.1016/s0035-9203(97)90382-5] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023] Open
Affiliation(s)
- E Castagnola
- Department of Infectious Diseases, G. Gaslini Children's Hospital, Genoa, Italy
| | | | | | | | | |
Collapse
|
49
|
Abstract
OBJECTIVE To actively detect leishmaniasis in HIV-1-infected individuals in Italy, to describe the epidemiological features of the disease in these patients, and to compare them with epidemiological features of leishmaniasis in HIV-negative patients. DESIGN Retrospective and prospective surveillance study. PATIENTS Italian patients with HIV-1 infection and leishmaniasis diagnosed between 1985 and 1994. RESULTS We recorded 116 leishmaniasis cases (115 visceral leishmaniasis), of which 94 (81%) were diagnosed over the last 4 years. Seventy-eight patients (67%) fulfilled the 1993 Centers for Disease Control and Prevention AIDS criteria. Leishmaniasis was passively reported in only 18% of cases. Leishmania incidence estimated among approximately 2700 AIDS patients living in leishmaniasis endemic areas averaged 1.6%, with a maximum of 4.9% in Sicily. These rates were up to 500-fold higher than among HIV-negative individuals living in the same areas, and were similar to those of ubiquitous opportunistic agents indicative of AIDS condition. Data from two major endemic regions indicated that overlap of HIV-1 and Leishmania infections has focal characteristics. The occurrence of small case clusters would suggest occasional modes of Leishmania transmission different from the insect vector. The isoenzyme characterization of 38 Leishmania stocks showed a zymodeme spectrum qualitatively and quantitatively different from that of the parasitic agent of visceral leishmaniasis in HIV-negative adults. CONCLUSIONS Active surveillance provided reliable evaluation on the occurrence of HIV-Leishmania coinfections in Italy, although it was limited to hospital-based cases in this study due to general under-reporting of cases. Biological and epidemiological spectrum of the disease suggests that visceral leishmaniasis should be included among AIDS-defining pathologies.
Collapse
Affiliation(s)
- L Gradoni
- Laboratory of Parasitology, Istituto Superiore di Sanità, Rome, Italy
| | | | | | | |
Collapse
|
50
|
Gradoni L, Pizzuti R, Scalone A, Russo M, Gramiccia M, di Martino L, Pempinello R, Gaeta GB. Recrudescence of visceral leishmaniasis unrelated to HIV infection in the Campania region of Italy. Trans R Soc Trop Med Hyg 1996; 90:234-5. [PMID: 8758059 DOI: 10.1016/s0035-9203(96)90226-6] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023] Open
Affiliation(s)
- L Gradoni
- Laboratorio di Parassitologia, Istituto Superiore di Sanità, Rome, Italy
| | | | | | | | | | | | | | | |
Collapse
|